KRNY 10-Q Quarterly Report March 31, 2022 | Alphaminr
Kearny Financial Corp.

KRNY 10-Q Quarter ended March 31, 2022

KEARNY FINANCIAL CORP.
10-Ks and 10-Qs
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
10-Q
10-Q
10-Q
10-K
PROXIES
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
DEF 14A
10-Q
2022 0001617242 false Q3 --06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2018-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2018-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2016-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2018-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 krny:PastDueLoansMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 krny:PastDueLoansMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember srt:MinimumMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2020-03-31 0001617242 krny:PerformanceBasedRsuMember krny:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001617242 krny:TermLoanMember 2020-06-30 0001617242 srt:MultifamilyMember 2021-01-01 2021-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2020-12-31 0001617242 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2022-01-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2016-06-30 0001617242 2021-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2017-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 us-gaap:CommonStockMember 2020-07-01 2021-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember 2022-03-31 0001617242 krny:TermLoanMember srt:MultifamilyMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2021-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2019-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2020-12-31 0001617242 krny:TroubledDebtRestructuringsMember srt:MultifamilyMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:SubstandardMember 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2020-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:RevolvingCreditFacilityMember 2021-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember krny:NonResidentialMortgageMember 2021-07-01 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember us-gaap:PassMember 2020-06-30 0001617242 srt:MultifamilyMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember 2020-07-01 2021-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:FairValueInputsLevel3Member srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2021-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:SubstandardMember 2022-03-31 0001617242 krny:OneToFourFamilyResidentialMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2018-06-30 0001617242 krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2021-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 krny:PastDueLoansMember srt:MultifamilyMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2017-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2019-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2017-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember 2021-07-01 2022-03-31 0001617242 krny:NonperformingLoansMember krny:OneToFourFamilyResidentialMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 krny:TermLoanMember 2017-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2021-01-01 2021-03-31 0001617242 us-gaap:RetainedEarningsMember 2020-07-01 2021-03-31 0001617242 krny:TroubledDebtRestructuringsMember 2022-01-01 2022-03-31 0001617242 krny:NonResidentialMortgageMember 2020-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2022-03-31 0001617242 us-gaap:LoanOriginationCommitmentsMember 2022-03-31 0001617242 krny:NonperformingLoansMember krny:NonResidentialMortgageMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 srt:MultifamilyMember 2020-07-01 2021-03-31 0001617242 krny:TermLoanMember srt:MultifamilyMember 2021-03-31 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2021-06-30 0001617242 krny:TwoThousandTwentyOneEquityIncentivePlanMember 2021-10-28 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2020-03-31 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember 2022-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:CollateralizedDebtObligationsMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2017-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2021-06-30 0001617242 us-gaap:CommonStockMember 2021-06-30 0001617242 us-gaap:FederalHomeLoanBankBorrowingsMember 2021-06-30 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember 2020-06-30 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-03-31 0001617242 us-gaap:CommonStockMember 2020-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 krny:PastDueLoansMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember 2021-07-01 2022-03-31 0001617242 us-gaap:CommonStockMember 2022-01-01 2022-03-31 0001617242 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2017-06-30 0001617242 krny:PerformanceBasedRsuMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember krny:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:CommercialPortfolioSegmentMember us-gaap:DoubtfulMember 2021-06-30 0001617242 us-gaap:DebtSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-06-30 0001617242 us-gaap:PassMember us-gaap:RevolvingCreditFacilityMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 krny:TermLoanMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember us-gaap:PassMember 2019-03-31 0001617242 krny:OtherConsumerLoansMember 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 krny:NonResidentialMortgageMember 2020-07-01 2021-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:MaturityOvernightMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:SubstandardMember 2016-06-30 0001617242 srt:MultifamilyMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:OneToFourFamilyResidentialMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2021-06-30 0001617242 krny:NonperformingLoansMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 us-gaap:RestrictedStockMember 2022-01-01 2022-03-31 0001617242 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2017-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2022-01-01 2022-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MinimumMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:IndividuallyAnalyzedLoansMember 2022-01-01 2022-03-31 0001617242 krny:TroubledDebtRestructuringsMember krny:NonAccrualMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueInputsLevel3Member krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MinimumMember krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2017-03-31 0001617242 krny:TroubledDebtRestructuringsMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:PastDueLoansMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember srt:MultifamilyMember 2019-03-31 0001617242 krny:UnearnedEsopSharesMember 2021-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:DoubtfulMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2022-03-31 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:MortgageBackedSecuritiesMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001617242 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:DoubtfulMember 2021-06-30 0001617242 krny:OtherRealEstateOwnedMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember 2022-01-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember 2021-06-30 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-06-30 0001617242 krny:PastDueLoansMember 2022-03-31 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:RevolvingCreditFacilityMember us-gaap:PassMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:PastDueLoansMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2019-03-31 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember us-gaap:MortgageBackedSecuritiesMember 2021-06-30 0001617242 2021-07-01 2022-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2022-01-01 2022-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2017-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2018-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember srt:MultifamilyMember 2020-07-01 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MinimumMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2019-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember srt:MultifamilyMember 2018-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2016-06-30 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2016-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember us-gaap:SubstandardMember 2017-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2022-01-01 2022-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2021-03-31 0001617242 us-gaap:AccumulatedGainLossNetCashFlowHedgeParentMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:SubstandardMember 2019-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueInputsLevel3Member krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:NonperformingLoansMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2019-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:DoubtfulMember 2016-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2020-06-30 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 krny:UnearnedEsopSharesMember 2021-01-01 2021-03-31 0001617242 us-gaap:RestrictedStockUnitsRSUMember krny:TwoThousandTwentyOneEquityIncentivePlanMember 2022-01-01 2022-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2020-07-01 2021-03-31 0001617242 us-gaap:AccumulatedDefinedBenefitPlansAdjustmentMember 2021-06-30 0001617242 us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:PastDueLoansMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2021-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2022-03-31 0001617242 us-gaap:InterestRateContractMember us-gaap:FairValueInputsLevel2Member 2022-03-31 0001617242 krny:NonResidentialMember 2021-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:CommonStockMember 2022-03-31 0001617242 us-gaap:FederalHomeLoanBankBorrowingsMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2017-03-31 0001617242 krny:NonResidentialMortgageMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:SpecialMentionMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 us-gaap:MortgageBackedSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-06-30 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2022-03-31 0001617242 krny:TermLoanMember 2018-06-30 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:NonResidentialMember 2022-03-31 0001617242 krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2020-07-01 2021-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:PassMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 srt:MultifamilyMember krny:NonperformingLoansMember 2021-06-30 0001617242 us-gaap:AdditionalPaidInCapitalMember 2020-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2021-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2017-03-31 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2019-03-31 0001617242 krny:TermLoanMember 2018-03-31 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 krny:NonResidentialMortgageMember 2021-12-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2022-03-31 0001617242 krny:NonResidentialMortgageMember 2021-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2016-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember krny:ConstructionReportablePortfolioSegmentMember us-gaap:CommercialLoanMember 2022-01-01 2022-03-31 0001617242 us-gaap:DoubtfulMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember 2022-01-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2016-06-30 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 us-gaap:FairValueInputsLevel2Member 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:PastDueLoansMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-06-30 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember srt:MultifamilyMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2020-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember krny:NonResidentialMortgageMember 2017-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember 2021-03-31 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember 2021-06-30 0001617242 krny:SalariesAndEmployeeBenefitsMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2022-01-01 2022-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:AccrualMember krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:AccrualMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:PassMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember 2021-06-30 0001617242 us-gaap:PassMember srt:MultifamilyMember 2021-06-30 0001617242 srt:MinimumMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-07-01 2022-03-31 0001617242 krny:NonResidentialMortgageMember 2021-07-01 2022-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-07-01 2021-03-31 0001617242 srt:WeightedAverageMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:PastDueLoansMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:SubstandardMember 2021-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember us-gaap:CommercialPortfolioSegmentMember krny:NonperformingLoansMember 2022-03-31 0001617242 krny:TermLoanMember srt:MultifamilyMember 2020-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2021-01-01 2021-03-31 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2021-06-30 0001617242 krny:UnearnedEsopSharesMember 2022-03-31 0001617242 us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:FederalReserveBankMember 2022-03-31 0001617242 us-gaap:OtherExpenseMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-01-01 2021-03-31 0001617242 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:SecurePublicFundsOnDepositMember 2021-06-30 0001617242 us-gaap:CommercialRealEstatePortfolioSegmentMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2021-06-30 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:PastDueLoansMember srt:MultifamilyMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2021-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2017-06-30 0001617242 krny:PastDueLoansMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:CommercialPortfolioSegmentMember us-gaap:DoubtfulMember 2022-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2017-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2018-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2021-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember krny:NonperformingLoansMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2017-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2021-03-31 0001617242 us-gaap:FairValueInputsLevel2Member krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2021-06-30 0001617242 2020-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2021-01-01 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:RevolvingCreditFacilityMember us-gaap:PassMember 2021-06-30 0001617242 krny:PastDueLoansMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 us-gaap:LoanOriginationCommitmentsMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:SubstandardMember 2017-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember 2020-07-01 2021-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2018-06-30 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2017-06-30 0001617242 krny:AccrualMember krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:PastDueLoansMember 2022-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember krny:NonAccrualMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2021-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember krny:OneToFourFamilyResidentialMember 2020-07-01 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2018-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:IndividuallyAnalyzedLoansMember 2020-07-01 2021-06-30 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:MortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember us-gaap:SubstandardMember 2016-06-30 0001617242 krny:OneToFourFamilyResidentialMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember srt:MultifamilyMember 2018-03-31 0001617242 krny:TermLoanMember 2019-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2016-06-30 0001617242 us-gaap:DoubtfulMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:RetainedEarningsMember 2022-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MaximumMember us-gaap:ResidentialPortfolioSegmentMember krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2020-07-01 2021-03-31 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-06-30 0001617242 us-gaap:CarryingReportedAmountFairValueDisclosureMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2016-06-30 0001617242 krny:NonResidentialMortgageMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2021-12-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2019-06-30 0001617242 srt:MultifamilyMember 2021-03-31 0001617242 krny:SalariesAndEmployeeBenefitsMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-07-01 2021-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2017-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember us-gaap:PassMember 2018-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2019-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2018-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember krny:AccrualMember 2021-06-30 0001617242 us-gaap:AdditionalPaidInCapitalMember 2021-06-30 0001617242 us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:SubstandardMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2020-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001617242 us-gaap:PassMember us-gaap:RevolvingCreditFacilityMember us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember 2021-06-30 0001617242 us-gaap:OtherExpenseMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2022-01-01 2022-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember 2020-07-01 2021-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:InterestRateContractMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2020-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:NonperformingLoansMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2016-06-30 0001617242 us-gaap:InterestRateContractMember 2021-06-30 0001617242 us-gaap:CommonStockMember 2021-12-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 krny:OtherConsumerLoansMember 2021-06-30 0001617242 us-gaap:PassMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember krny:NonResidentialMortgageMember 2017-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2022-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2018-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2021-12-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember 2022-03-31 0001617242 us-gaap:DebtSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2022-03-31 0001617242 krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2021-06-30 0001617242 krny:NonperformingLoansMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:PastDueLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2022-03-31 0001617242 us-gaap:CashFlowHedgingMember us-gaap:InterestRateSwapMember 2022-03-31 0001617242 us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2017-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:RevolvingCreditFacilityMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember 2020-07-01 2021-03-31 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2022-03-31 0001617242 srt:MultifamilyMember 2020-12-31 0001617242 us-gaap:HomeEquityLoanMember 2020-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember 2021-01-01 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2021-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember krny:TermLoanMember 2017-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2019-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:InvestmentInFederalHomeLoanBankStockMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember srt:MultifamilyMember 2019-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:DoubtfulMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MaximumMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2017-06-30 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember srt:MultifamilyMember 2020-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:TermLoanMember 2016-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 krny:UnearnedEsopSharesMember 2020-12-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember 2021-06-30 0001617242 krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2022-03-31 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivables60To89DaysPastDueMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2020-06-30 0001617242 srt:MultifamilyMember 2020-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2021-06-30 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2020-12-31 0001617242 us-gaap:CollateralizedDebtObligationsMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 us-gaap:RetainedEarningsMember 2021-07-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 krny:CallsOfSecuritiesMember 2021-07-01 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember krny:NonResidentialMortgageMember 2018-06-30 0001617242 us-gaap:FinancialAssetNotPastDueMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:SubstandardMember 2021-06-30 0001617242 krny:OneToFourFamilyResidentialMember 2020-07-01 2021-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2018-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2018-03-31 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2020-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2020-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:USStatesAndPoliticalSubdivisionsMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember 2021-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2020-12-31 0001617242 2021-01-01 2021-03-31 0001617242 krny:TwoThousandTwentyOneEquityIncentivePlanMember us-gaap:ShareBasedCompensationAwardTrancheThreeMember krny:ServiceBasedRsuMember 2022-01-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:PassMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2021-06-30 0001617242 krny:OneToFourFamilyResidentialMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 krny:OneToFourFamilyResidentialMember 2021-12-31 0001617242 krny:TroubledDebtRestructuringsMember krny:AccrualMember 2021-06-30 0001617242 2022-04-29 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2019-06-30 0001617242 krny:NonResidentialMortgageMember 2021-01-01 2021-03-31 0001617242 us-gaap:FinancialAssetNotPastDueMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:RetainedEarningsMember srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2021-12-31 0001617242 krny:UnearnedEsopSharesMember 2020-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2019-03-31 0001617242 us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2022-03-31 0001617242 us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 srt:WeightedAverageMember 2022-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2020-06-30 0001617242 krny:NonperformingLoansMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember srt:SingleFamilyMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001617242 krny:TroubledDebtRestructuringsMember srt:MultifamilyMember 2021-07-01 2022-03-31 0001617242 us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2022-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:SpecialMentionMember 2016-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2017-06-30 0001617242 us-gaap:AdditionalPaidInCapitalMember 2021-01-01 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2019-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2016-06-30 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-12-31 0001617242 krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember us-gaap:PassMember 2018-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2018-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2021-12-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember krny:AccrualMember 2022-03-31 0001617242 krny:TermLoanMember 2021-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2017-06-30 0001617242 krny:TermLoanMember 2019-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2017-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-06-30 0001617242 krny:NonperformingLoansMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:NonperformingFinancingReceivableMember srt:MultifamilyMember krny:NonperformingLoansMember 2021-06-30 0001617242 srt:MultifamilyMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2020-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2018-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2018-06-30 0001617242 srt:FederalHomeLoanBankOfNewYorkMember 2021-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:CommercialMortgageBackedSecuritiesMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember krny:AccrualMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember 2021-06-30 0001617242 srt:MultifamilyMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2017-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2017-03-31 0001617242 krny:UnearnedEsopSharesMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2019-03-31 0001617242 2021-12-31 0001617242 2022-01-01 2022-03-31 0001617242 krny:PastDueLoansMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:FederalReserveBankMember 2021-06-30 0001617242 krny:PastDueLoansMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2017-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember us-gaap:ResidentialPortfolioSegmentMember krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-06-30 0001617242 us-gaap:FairValueMeasurementsNonrecurringMember 2020-07-01 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2017-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2021-06-30 0001617242 us-gaap:DebtSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2021-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2020-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2016-06-30 0001617242 us-gaap:HeldtomaturitySecuritiesMember 2022-03-31 0001617242 krny:CARESMember 2020-12-26 2020-12-27 0001617242 krny:PastDueLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:CollateralizedDebtObligationsMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 us-gaap:MaturityOvernightMember 2022-03-31 0001617242 us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:InterestRateContractMember 2022-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember krny:TermLoanMember 2019-06-30 0001617242 krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember krny:NonResidentialMortgageMember 2018-03-31 0001617242 us-gaap:HomeEquityLoanMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2022-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2017-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2018-06-30 0001617242 srt:MultifamilyMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:SpecialMentionMember 2017-03-31 0001617242 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherLiabilitiesMember 2021-06-30 0001617242 krny:OneToFourFamilyResidentialMember 2020-06-30 0001617242 us-gaap:HeldtomaturitySecuritiesMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ResidentialPortfolioSegmentMember 2017-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember srt:MultifamilyMember 2021-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember 2022-01-01 2022-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 2021-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2021-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:SubstandardMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2022-03-31 0001617242 krny:SecurePublicFundsOnDepositMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember krny:NonResidentialMortgageMember 2020-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2018-03-31 0001617242 us-gaap:SubstandardMember srt:MultifamilyMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember 2020-07-01 2021-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2017-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember srt:MultifamilyMember 2016-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2018-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember srt:MultifamilyMember 2021-03-31 0001617242 krny:NonResidentialMortgageMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2018-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2022-01-01 2022-03-31 0001617242 krny:MSBFinancialCorporationMember 2020-07-01 2021-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember krny:OneToFourFamilyResidentialMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember 2017-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:SubstandardMember 2017-03-31 0001617242 us-gaap:AssetBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 krny:PastDueLoansMember krny:OneToFourFamilyResidentialMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2022-03-31 0001617242 us-gaap:SubstandardMember srt:MultifamilyMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2020-06-30 0001617242 us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2021-06-30 0001617242 srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2020-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 krny:TroubledDebtRestructuringsMember krny:AccrualMember 2022-03-31 0001617242 us-gaap:SpecialMentionMember srt:MultifamilyMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2016-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2019-03-31 0001617242 srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 krny:UnearnedEsopSharesMember 2020-07-01 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2020-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2016-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember srt:MultifamilyMember 2018-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 us-gaap:CommonStockMember 2021-03-31 0001617242 us-gaap:FairValueInputsLevel2Member 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2020-06-30 0001617242 us-gaap:CommercialRealEstatePortfolioSegmentMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2018-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-01-01 2021-03-31 0001617242 2020-12-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2017-06-30 0001617242 srt:MaximumMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember krny:NonResidentialMortgageMember 2019-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-06-30 0001617242 krny:NonperformingLoansMember krny:NonResidentialMortgageMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2016-06-30 0001617242 krny:NonperformingLoansMember 2021-06-30 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2020-07-01 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember 2021-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember 2021-01-01 2021-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MaximumMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember 2020-07-01 2021-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 krny:NonperformingLoansMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2020-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember 2021-06-30 0001617242 krny:PastDueLoansMember srt:MultifamilyMember 2021-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2018-06-30 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2019-06-30 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2018-06-30 0001617242 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2020-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2017-03-31 0001617242 krny:NonResidentialMortgageMember 2020-12-31 0001617242 us-gaap:CommercialMortgageBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2020-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:DoubtfulMember 2022-03-31 0001617242 krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 krny:OtherRealEstateOwnedMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:SpecialMentionMember 2021-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember 2020-07-01 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:NonperformingLoansMember 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2022-03-31 0001617242 krny:NonperformingLoansMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember 2020-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:PastDueLoansMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 srt:MultifamilyMember 2021-07-01 2022-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2018-06-30 0001617242 srt:CumulativeEffectPeriodOfAdoptionAdjustmentMember 2020-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2021-03-31 0001617242 us-gaap:CommonStockMember 2020-12-31 0001617242 krny:TermLoanMember us-gaap:PassMember srt:MultifamilyMember 2019-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2018-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2019-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2019-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember krny:NonResidentialMortgageMember 2016-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember krny:CollateralDependentLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:PassMember us-gaap:RevolvingCreditFacilityMember us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:InvestmentInFederalHomeLoanBankStockMember 2021-06-30 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember 2021-01-01 2021-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember srt:MultifamilyMember 2021-07-01 2022-03-31 0001617242 krny:NonperformingLoansMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2016-06-30 0001617242 2020-07-01 2021-06-30 0001617242 srt:MultifamilyMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2022-03-31 0001617242 us-gaap:OtherExpenseMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2020-07-01 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember 2021-07-01 2022-03-31 0001617242 krny:ConsumerSegmentMember 2022-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember 2021-07-01 2022-03-31 0001617242 krny:UnearnedEsopSharesMember 2021-07-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2018-06-30 0001617242 krny:PastDueLoansMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:AvailableforsaleSecuritiesMember 2022-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember 2020-12-31 0001617242 srt:FederalHomeLoanBankOfNewYorkMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SubstandardMember srt:MultifamilyMember 2017-03-31 0001617242 krny:TroubledDebtRestructuringsMember 2021-01-01 2021-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 krny:OneToFourFamilyResidentialMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2021-06-30 0001617242 us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:ResidentialPortfolioSegmentMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2017-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember krny:TermLoanMember 2018-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember us-gaap:RevolvingCreditFacilityMember 2022-03-31 0001617242 us-gaap:CommonStockMember 2021-07-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:SpecialMentionMember us-gaap:CommercialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:AdditionalPaidInCapitalMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2017-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember us-gaap:MortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 us-gaap:CommonStockMember 2021-01-01 2021-03-31 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2019-06-30 0001617242 us-gaap:InterestExpenseMember 2021-07-01 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2021-01-01 2021-03-31 0001617242 krny:NonperformingLoansMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:NonperformingFinancingReceivableMember srt:MultifamilyMember krny:NonperformingLoansMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2021-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember srt:MultifamilyMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember 2021-06-30 0001617242 us-gaap:CollateralizedDebtObligationsMember us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:ResidentialMortgageBackedSecuritiesMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2021-03-31 0001617242 us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:HeldtomaturitySecuritiesMember 2021-06-30 0001617242 2020-07-01 2021-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:AssetBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember 2021-06-30 0001617242 krny:CallsOfSecuritiesMember 2020-07-01 2021-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember srt:MultifamilyMember 2022-01-01 2022-03-31 0001617242 us-gaap:InterestRateContractMember us-gaap:DesignatedAsHedgingInstrumentMember us-gaap:OtherAssetsMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2016-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MinimumMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:TermLoanMember srt:MultifamilyMember 2019-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:MortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2021-03-31 0001617242 srt:MultifamilyMember 2021-12-31 0001617242 us-gaap:HomeEquityLoanMember krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2017-06-30 0001617242 srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:RealEstateAcquiredInSatisfactionOfDebtMember srt:SingleFamilyMember 2021-06-30 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:FairValueInputsLevel2Member krny:CollateralizedMortgageObligationsExcludingPassThroughSecuritiesMember 2022-03-31 0001617242 krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2021-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MaximumMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 us-gaap:FairValueInputsLevel1Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2021-07-01 2022-03-31 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:DebtSecuritiesMember us-gaap:CorporateDebtSecuritiesMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember us-gaap:PassMember 2016-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2018-03-31 0001617242 krny:PastDueLoansMember krny:OneToFourFamilyResidentialMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2019-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember srt:MultifamilyMember 2017-06-30 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:OneToFourFamilyResidentialMember 2022-01-01 2022-03-31 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember us-gaap:CommercialPortfolioSegmentMember krny:NonAccrualMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:SpecialMentionMember srt:MultifamilyMember 2017-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2020-06-30 0001617242 srt:MinimumMember us-gaap:FairValueMeasurementsNonrecurringMember 2020-07-01 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember srt:MultifamilyMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2017-03-31 0001617242 krny:PastDueLoansMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:PastDueLoansMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:PastDueLoansMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2018-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember srt:MultifamilyMember 2018-03-31 0001617242 krny:PastDueLoansMember us-gaap:FinancingReceivables60To89DaysPastDueMember krny:OneToFourFamilyResidentialMember 2021-06-30 0001617242 us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2022-03-31 0001617242 us-gaap:FairValueMeasurementsNonrecurringMember 2021-07-01 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember krny:NonperformingLoansMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2018-06-30 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 srt:MultifamilyMember 2022-01-01 2022-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2022-03-31 0001617242 krny:SalariesAndEmployeeBenefitsMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-07-01 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:NonperformingFinancingReceivableMember krny:NonperformingLoansMember 2022-03-31 0001617242 us-gaap:DebtSecuritiesMember us-gaap:ResidentialMortgageBackedSecuritiesMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2018-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember krny:OneToFourFamilyResidentialMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2018-06-30 0001617242 krny:PastDueLoansMember us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancingReceivablesEqualToGreaterThan90DaysPastDueMember 2022-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember srt:MultifamilyMember 2021-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MaximumMember krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2020-07-01 2021-06-30 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember krny:NonResidentialMortgageMember 2020-07-01 2021-06-30 0001617242 us-gaap:CashFlowHedgingMember 2022-01-01 2022-03-31 0001617242 us-gaap:OtherExpenseMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-07-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:CommercialPortfolioSegmentMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember us-gaap:SubstandardMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember us-gaap:CommercialLoanMember krny:NonResidentialMortgageMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember us-gaap:FinancialAssetNotPastDueMember 2021-06-30 0001617242 krny:SalariesAndEmployeeBenefitsMember us-gaap:SupplementalEmployeeRetirementPlanDefinedBenefitMember 2021-01-01 2021-03-31 0001617242 us-gaap:PassMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 krny:CollateralDependentLoansMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2021-03-31 0001617242 krny:IndividuallyAnalyzedLoansMember 2021-07-01 2022-03-31 0001617242 us-gaap:AccumulatedOtherComprehensiveIncomeMember 2021-03-31 0001617242 us-gaap:SpecialMentionMember us-gaap:ResidentialPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2020-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2020-06-30 0001617242 us-gaap:FairValueInputsLevel2Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-03-31 0001617242 us-gaap:CashFlowHedgingMember 2021-07-01 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:AccumulatedNetUnrealizedInvestmentGainLossMember 2022-03-31 0001617242 us-gaap:ResidentialPortfolioSegmentMember us-gaap:RealEstateAcquiredInSatisfactionOfDebtMember srt:SingleFamilyMember 2022-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2021-07-01 2022-03-31 0001617242 us-gaap:FairValueInputsLevel3Member us-gaap:EstimateOfFairValueFairValueDisclosureMember 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2017-03-31 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2020-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 krny:OtherRealEstateOwnedMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 us-gaap:EmployeeStockOptionMember 2020-07-01 2021-03-31 0001617242 us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 krny:CallsOfSecuritiesMember 2021-01-01 2021-03-31 0001617242 krny:TermLoanMember krny:NonResidentialMortgageMember 2020-06-30 0001617242 us-gaap:PassMember us-gaap:CommercialPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:RetainedEarningsMember 2021-12-31 0001617242 krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2022-01-01 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:NonperformingLoansMember 2022-03-31 0001617242 us-gaap:SpecialMentionMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2020-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2021-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2021-06-30 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2017-03-31 0001617242 us-gaap:FinancialAssetAcquiredWithCreditDeteriorationMember 2021-06-30 0001617242 krny:TroubledDebtRestructuringsMember krny:NonAccrualMember 2022-03-31 0001617242 krny:NonperformingLoansMember us-gaap:PerformingFinancingReceivableMember us-gaap:ConsumerPortfolioSegmentMember 2022-03-31 0001617242 us-gaap:SpecialMentionMember srt:MultifamilyMember 2022-03-31 0001617242 us-gaap:RevolvingCreditFacilityMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:CollateralDependentLoansMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember 2019-06-30 0001617242 krny:TroubledDebtRestructuringsMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2019-06-30 0001617242 us-gaap:CommercialLoanMember krny:TroubledDebtRestructuringsMember krny:AccrualMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 us-gaap:HomeEquityLoanMember us-gaap:PassMember krny:TermLoanMember 2017-06-30 0001617242 krny:TermLoanMember us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2016-06-30 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember krny:CollateralDependentLoansMember srt:MinimumMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:OtherRealEstateOwnedMember us-gaap:FairValueInputsLevel3Member us-gaap:FairValueMeasurementsNonrecurringMember 2022-03-31 0001617242 us-gaap:FinancingReceivables30To59DaysPastDueMember krny:PastDueLoansMember krny:NonResidentialMortgageMember 2022-03-31 0001617242 us-gaap:PassMember krny:TermLoanMember krny:NonResidentialMortgageMember 2021-03-31 0001617242 us-gaap:SubstandardMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:UnearnedEsopSharesMember 2021-12-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2020-03-31 0001617242 krny:NonperformingLoansMember krny:OneToFourFamilyResidentialMember us-gaap:PerformingFinancingReceivableMember 2021-06-30 0001617242 us-gaap:PassMember krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember 2018-06-30 0001617242 us-gaap:DebtSecuritiesMember 2022-03-31 0001617242 us-gaap:EmployeeStockOptionMember 2021-07-01 2022-03-31 0001617242 krny:UnearnedEsopSharesMember 2022-01-01 2022-03-31 0001617242 us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 krny:ConstructionReportablePortfolioSegmentMember us-gaap:PassMember krny:TermLoanMember 2016-06-30 0001617242 krny:TermLoanMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:FairValueInputsLevel3Member krny:ImpairedLoansMember 2022-03-31 0001617242 us-gaap:AdditionalPaidInCapitalMember 2022-01-01 2022-03-31 0001617242 us-gaap:AssetBackedSecuritiesMember us-gaap:DebtSecuritiesMember 2021-06-30 0001617242 krny:CallsOfSecuritiesMember 2022-01-01 2022-03-31 0001617242 us-gaap:PassMember us-gaap:RevolvingCreditFacilityMember krny:NonResidentialMortgageMember 2021-06-30 0001617242 krny:PastDueLoansMember us-gaap:FinancialAssetNotPastDueMember 2022-03-31 0001617242 krny:AdjustmentsToReflectCurrentConditionsOrSellingCostsMember srt:MaximumMember krny:CollateralDependentLoansMember krny:NonResidentialMortgageMember us-gaap:FairValueMeasurementsNonrecurringMember us-gaap:MarketApproachValuationTechniqueMember 2021-07-01 2022-03-31 0001617242 krny:ConsumerSegmentMember 2021-06-30 0001617242 us-gaap:SubstandardMember us-gaap:ConsumerPortfolioSegmentMember 2021-06-30 0001617242 us-gaap:TrustPreferredSecuritiesSubjectToMandatoryRedemptionMember us-gaap:USStatesAndPoliticalSubdivisionsMember 2022-03-31 0001617242 us-gaap:CommercialPortfolioSegmentMember 2021-07-01 2022-03-31 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:SubstandardMember 2016-06-30 0001617242 krny:AccrualMember krny:TroubledDebtRestructuringsMember krny:OneToFourFamilyResidentialMember 2022-03-31 0001617242 us-gaap:CommercialLoanMember us-gaap:CommercialPortfolioSegmentMember krny:AccrualMember krny:TroubledDebtRestructuringsMember 2021-06-30 0001617242 krny:TwoThousandTwentyOneEquityIncentivePlanMember krny:ServiceBasedRsuMember 2022-01-01 2022-03-31 0001617242 krny:ConstructionReportablePortfolioSegmentMember krny:TermLoanMember 2018-06-30 0001617242 krny:TermLoanMember us-gaap:CommercialPortfolioSegmentMember us-gaap:DoubtfulMember 2017-03-31 0001617242 krny:TermLoanMember us-gaap:ResidentialPortfolioSegmentMember us-gaap:SubstandardMember 2017-06-30 0001617242 us-gaap:CommercialLoanMember krny:AccrualMember krny:TroubledDebtRestructuringsMember 2022-03-31 0001617242 us-gaap:HomeEquityLoanMember krny:TermLoanMember 2019-06-30 0001617242 us-gaap:HomeEquityLoanMember krny:PastDueLoansMember us-gaap:FinancingReceivables60To89DaysPastDueMember 2021-06-30 krny:Loan krny:Instrument xbrli:pure krny:Property xbrli:shares krny:Securities krny:Security iso4217:USD xbrli:shares iso4217:USD

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended March 31, 2022

OR

TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number 001-37399

KEARNY FINANCIAL CORP.

(Exact name of registrant as specified in its charter)

Maryland

30-0870244

(State or other jurisdiction of
incorporation or organization)

(I.R.S. Employer
Identification Number)

120 Passaic Ave. , Fairfield , New Jersey

07004

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code

973 - 244-4500

Securities registered pursuant to Section 12(b) of the Act:

Title of each class

Trading Symbol(s)

Name of each exchange on which registered

Common Stock, $0.01 par value

KRNY

The NASDAQ Stock Market LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☒ No ☐

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filers,” “accelerated filers,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☐ No

The number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date: April 29, 2022.

$0.01 par value common stock — 70,421,270 shares outstanding


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

INDEX

Page

Number

PART I—FINANCIAL INFORMATION

Item 1.

Financial Statements

Consolidated Statements of Financial Condition at March 31, 2022 (Unaudited) and June 30, 2021

1

Consolidated Statements of Income for the Three Months and Nine Months Ended March 31, 2022 and March 31, 2021 (Unaudited)

2

Consolidated Statements of Comprehensive Income (Loss) for the Three Months and Nine Months Ended March 31, 2022 and March 31, 2021 (Unaudited)

3

Consolidated Statements of Changes in Stockholders’ Equity for the Three Months and Nine Months Ended March 31, 2022 and March 31, 2021 (Unaudited)

4

Consolidated Statements of Cash Flows for the Nine Months Ended March 31, 2022 and March 31, 2021 (Unaudited)

6

Notes to Consolidated Financial Statements (Unaudited)

8

Item 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

39

Item 3.

Quantitative and Qualitative Disclosure About Market Risk

51

Item 4.

Controls and Procedures

52

PART II—OTHER INFORMATION

Item 1.

Legal Proceedings

53

Item 1A.

Risk Factors

53

Item 2.

Unregistered Sales of Equity Securities and Use of Proceeds

53

Item 3.

Defaults Upon Senior Securities

53

Item 4.

Mine Safety Disclosures

53

Item 5.

Other Information

53

Item 6.

Exhibits

54

SIGNATURES

55


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

C ONSOLIDATED STATEMENTS OF FINANCIAL CONDITION

(In Thousands, Except Share and Per Share Data)

March 31,

June 30,

2022

2021

(Unaudited)

Assets

Cash and amounts due from depository institutions

$

22,864

$

21,463

Interest-bearing deposits in other banks

39,515

46,392

Cash and cash equivalents

62,379

67,855

Investment securities available for sale (amortized cost $ 1,590,074 and $ 1,666,853 ,
respectively), net of allowance for credit losses of $
0 at March 31, 2022 and June 30, 2021

1,526,086

1,676,864

Investment securities held to maturity (fair value $ 117,017 and $ 39,610 , respectively), net of
allowance for credit losses of $
0 at March 31, 2022 and June 30, 2021

121,853

38,138

Loans held-for-sale

2,822

16,492

Loans receivable

5,003,201

4,851,394

Less: allowance for credit losses on loans

( 43,860

)

( 58,165

)

Net loans receivable

4,959,341

4,793,229

Premises and equipment

53,727

56,338

Federal Home Loan Bank (“FHLB”) of New York stock

30,997

36,615

Accrued interest receivable

19,517

19,362

Goodwill

210,895

210,895

Core deposit intangibles

3,166

3,705

Bank owned life insurance

287,644

283,310

Deferred income tax assets, net

34,349

29,323

Other real estate owned

401

178

Other assets

76,714

51,431

Total Assets

$

7,389,891

$

7,283,735

Liabilities and Stockholders' Equity

Liabilities

Deposits:

Non-interest-bearing

$

621,954

$

593,718

Interest-bearing

4,906,708

4,891,588

Total deposits

5,528,662

5,485,306

Borrowings

851,220

685,876

Advance payments by borrowers for taxes

16,979

15,752

Other liabilities

37,861

53,857

Total Liabilities

6,434,722

6,240,791

Stockholders' Equity

Preferred stock, $ 0.01 par value, 100,000,000 shares authorized;
none issued and outstanding

-

-

Common stock, $ 0.01 par value; 800,000,000 shares authorized;
71,424,469 shares and 78,964,859 shares issued and outstanding, respectively

714

790

Paid-in capital

561,176

654,396

Retained earnings

441,522

408,367

Unearned employee stock ownership plan shares;
2,609,069 shares and 2,759,594 shares, respectively

( 25,294

)

( 26,753

)

Accumulated other comprehensive (loss) income

( 22,949

)

6,144

Total Stockholders' Equity

955,169

1,042,944

Total Liabilities and Stockholders' Equity

$

7,389,891

$

7,283,735

See notes to unaudited consolidated financial statements.

- 1 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF INCOME

(In Thousands, Except Per Share Data)

(Unaudited)

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

Interest Income

Loans

$

45,846

$

50,159

$

141,651

$

153,776

Taxable investment securities

8,024

7,891

23,831

22,934

Tax-exempt investment securities

316

410

976

1,297

Other interest-earning assets

415

705

1,261

2,406

Total Interest Income

54,601

59,165

167,719

180,413

Interest Expense

Deposits

3,565

6,670

11,293

26,379

Borrowings

3,309

4,012

10,422

14,865

Total Interest Expense

6,874

10,682

21,715

41,244

Net Interest Income

47,727

48,483

146,004

139,169

(Reversal of) provision for credit losses

( 3,920

)

1,126

( 11,740

)

3,820

Net Interest Income after (Reversal of)
Provision for Credit Losses

51,647

47,357

157,744

135,349

Non-Interest Income

Fees and service charges

617

473

1,922

1,474

Gain on sale and call of securities

3

18

4

454

Gain on sale of loans

376

943

2,352

5,211

Gain on sale of other real estate owned

14

-

14

-

Income from bank owned life insurance

1,511

1,530

4,634

4,722

Electronic banking fees and charges

432

456

1,260

1,265

Bargain purchase gain

-

-

-

3,053

Other income

238

1,194

938

1,351

Total Non-Interest Income

3,191

4,614

11,124

17,530

Non-Interest Expense

Salaries and employee benefits

19,184

16,965

55,897

51,023

Net occupancy expense of premises

3,223

3,433

10,926

9,675

Equipment and systems

3,822

3,823

11,370

11,295

Advertising and marketing

516

567

1,356

1,580

Federal deposit insurance premium

480

488

1,693

1,450

Directors' compensation

340

748

1,792

2,244

Merger-related expenses

-

-

-

4,349

Debt extinguishment expenses

-

-

-

796

Other expense

3,058

3,792

9,062

11,487

Total Non-Interest Expense

30,623

29,816

92,096

93,899

Income before Income Taxes

24,215

22,155

76,772

58,980

Income tax expense

6,522

5,732

20,595

14,230

Net Income

$

17,693

$

16,423

$

56,177

$

44,750

Net Income per Common Share (EPS)

Basic

$

0.25

$

0.20

$

0.78

$

0.53

Diluted

$

0.25

$

0.20

$

0.78

$

0.53

Weighted Average Number of Common Shares
Outstanding

Basic

69,790

80,673

72,130

83,958

Diluted

69,817

80,690

72,154

83,961

See notes to unaudited consolidated financial statements.

- 2 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)

(In Thousands, Unaudited)

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

Net Income

$

17,693

$

16,423

$

56,177

$

44,750

Other Comprehensive (Loss) Income, net of tax:

Net unrealized loss on securities available for sale

( 41,922

)

( 15,671

)

( 52,354

)

( 14,379

)

Net realized gain on sale and call of securities
available for sale

( 2

)

( 13

)

( 3

)

( 319

)

Fair value adjustments on derivatives

17,387

10,574

23,227

14,750

Benefit plan adjustments

14

14

37

48

Total Other Comprehensive (Loss) Income

( 24,523

)

( 5,096

)

( 29,093

)

100

Total Comprehensive (Loss) Income

$

( 6,830

)

$

11,327

$

27,084

$

44,850

See notes to unaudited consolidated financial statements.

- 3 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(In Thousands, Except Per Share Data, Unaudited)

Common Stock

Paid-In

Retained

Unearned
ESOP

Accumulated
Other
Comprehensive

Shares

Amount

Capital

Earnings

Shares

Income

Total

Balance - December 31, 2020

84,938

$

849

$

724,389

$

388,376

$

( 27,726

)

$

6,453

$

1,092,341

Net income

-

-

-

16,423

-

-

16,423

Other comprehensive loss, net
of income tax

-

-

-

-

-

( 5,096

)

( 5,096

)

ESOP shares committed to be
released (
50 shares)

-

-

87

-

487

-

574

Stock option exercise

41

-

373

-

-

-

373

Share repurchases

( 3,026

)

( 29

)

( 34,834

)

-

-

-

( 34,863

)

Stock-based compensation expense

-

-

1,379

-

-

-

1,379

Cancellation of shares issued for
restricted stock awards

( 10

)

-

( 114

)

-

-

-

( 114

)

Cash dividends declared
($
0.09 per common share)

-

-

-

( 7,205

)

-

-

( 7,205

)

Balance - March 31, 2021

81,943

$

820

$

691,280

$

397,594

$

( 27,239

)

$

1,357

$

1,063,812

Common Stock

Paid-In

Retained

Unearned
ESOP

Accumulated
Other
Comprehensive

Shares

Amount

Capital

Earnings

Shares

Income

Total

Balance - June 30, 2020

83,663

$

837

$

722,871

$

387,911

$

( 28,699

)

$

1,257

$

1,084,177

Cumulative effect of change in
accounting principle - Topic 326

-

-

-

( 14,239

)

-

-

( 14,239

)

Balance - July 1, 2020 as
adjusted for change in
accounting principle

83,663

837

722,871

373,672

( 28,699

)

1,257

1,069,938

Net income

-

-

-

44,750

-

-

44,750

Other comprehensive income, net
of income tax

-

-

-

-

-

100

100

ESOP shares committed to be
released (
150 shares)

-

-

( 25

)

-

1,460

-

1,435

Stock option exercise

41

-

373

-

-

-

373

Stock repurchases

( 7,535

)

( 74

)

( 80,493

)

-

-

-

( 80,567

)

Stock-based compensation expense

-

-

4,281

-

-

-

4,281

Cancellation of shares issued for
restricted stock awards

( 80

)

( 1

)

( 802

)

-

-

-

( 803

)

Shares issued in conjunction with
the acquisition of MSB
Financial Corp.

5,854

58

45,075

-

-

-

45,133

Cash dividends declared
($
0.25 per common share)

-

-

-

( 20,828

)

-

-

( 20,828

)

Balance - March 31, 2021

81,943

$

820

$

691,280

$

397,594

$

( 27,239

)

$

1,357

$

1,063,812

See notes to unaudited consolidated financial statements.

- 4 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ EQUITY

(In Thousands, Except Per Share Data, Unaudited)

Common Stock

Paid-In

Retained

Unearned
ESOP

Accumulated
Other
Comprehensive

Shares

Amount

Capital

Earnings

Shares

Income (Loss)

Total

Balance - December 31, 2021

73,453

$

735

$

587,392

$

431,549

$

( 25,780

)

$

1,574

$

995,470

Net income

-

-

-

17,693

-

-

17,693

Other comprehensive loss, net
of income tax

-

-

-

-

-

( 24,523

)

( 24,523

)

ESOP shares committed to be
released (
51 shares)

-

-

180

-

486

-

666

Stock repurchases

( 2,020

)

( 21

)

( 26,948

)

-

-

-

( 26,969

)

Stock-based compensation expense

-

-

676

-

-

-

676

Cancellation of shares issued for
restricted stock awards

( 9

)

-

( 124

)

-

-

-

( 124

)

Cash dividends declared
($
0.11 per common share)

-

-

-

( 7,720

)

-

-

( 7,720

)

Balance - March 31, 2022

71,424

$

714

$

561,176

$

441,522

$

( 25,294

)

$

( 22,949

)

$

955,169

Common Stock

Paid-In

Retained

Unearned
ESOP

Accumulated
Other
Comprehensive

Shares

Amount

Capital

Earnings

Shares

Income (Loss)

Total

Balance - June 30, 2021

78,965

$

790

$

654,396

$

408,367

$

( 26,753

)

$

6,144

$

1,042,944

Net income

-

-

-

56,177

-

-

56,177

Other comprehensive loss, net
of income tax

-

-

-

-

-

( 29,093

)

( 29,093

)

ESOP shares committed to be
released (
151 shares)

-

-

486

-

1,459

-

1,945

Stock repurchases

( 7,468

)

( 75

)

( 95,892

)

-

-

-

( 95,967

)

Stock-based compensation expense

-

-

3,117

-

-

-

3,117

Cancellation of shares issued for
restricted stock awards

( 73

)

( 1

)

( 931

)

-

-

-

( 932

)

Cash dividends declared
($
0.32 per common share)

-

-

-

( 23,022

)

-

-

( 23,022

)

Balance - March 31, 2022

71,424

$

714

$

561,176

$

441,522

$

( 25,294

)

$

( 22,949

)

$

955,169

See notes to unaudited consolidated financial statements.

- 5 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS

(In Thousands, Unaudited)

Nine Months Ended

March 31,

2022

2021

Cash Flows from Operating Activities:

Net income

$

56,177

$

44,750

Adjustment to reconcile net income to net cash provided by operating activities:

Depreciation and amortization of premises and equipment

4,470

4,355

Net accretion of premiums, discounts and loan fees and costs

( 4,374

)

( 11,257

)

Deferred income taxes and valuation allowance

6,943

3,004

Bargain purchase gain

-

( 3,053

)

Amortization of intangible assets

539

797

Amortization of benefit plans’ unrecognized net loss

60

62

(Reversal of) provision for credit losses

( 11,740

)

3,820

Gain on sale of other real estate owned

( 14

)

-

Loans originated for sale

( 151,783

)

( 249,671

)

Proceeds from sale of mortgage loans held-for-sale

167,713

270,147

Gain on sale of mortgage loans held-for-sale, net

( 2,260

)

( 4,859

)

Realized gain on sale/call of investment securities available for sale

( 4

)

( 454

)

Realized loss on debt extinguishment

-

796

Realized gain on sale of loans receivable

( 92

)

( 352

)

Realized (gain) loss on disposition of premises and equipment

( 356

)

40

Increase in cash surrender value of bank owned life insurance

( 4,634

)

( 4,722

)

ESOP and stock-based compensation expense

5,062

5,716

Increase in interest receivable

( 155

)

( 1,488

)

Decrease (increase) in other assets

6,679

( 1,021

)

Increase (decrease) in interest payable

49

( 406

)

(Decrease) increase in other liabilities

( 15,125

)

1,519

Net Cash Provided by Operating Activities

57,155

57,723

Cash Flows from Investing Activities:

Purchases of:

Investment securities available for sale

( 206,145

)

( 865,163

)

Investment securities held to maturity

( 86,406

)

-

Proceeds from:

Repayments/calls/maturities of investment securities available for sale

280,496

407,489

Repayments/calls/maturities of investment securities held to maturity

2,586

5,280

Sales of investment securities available for sale

-

44,842

Purchase of loans

( 112,485

)

( 34,635

)

Net (increase) decrease in loans receivable

( 36,895

)

237,383

Proceeds from sale of loans receivable

1,126

43,931

Proceeds from the sale of other real estate owned

494

-

Additions to premises and equipment

( 1,859

)

( 2,889

)

Proceeds from death benefit of bank owned life insurance

300

-

Proceeds from cash settlement of premises and equipment

599

3,401

Redemption of FHLB stock

5,618

16,421

Net cash acquired in acquisition

-

4,296

Net Cash Used in Investing Activities

$

( 152,571

)

$

( 139,644

)

See notes to unaudited consolidated financial statements.

- 6 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

CONSOLIDATED STATEMENTS OF CASH FLOWS (Continued)

(In Thousands, Unaudited)

Nine Months Ended

March 31,

2022

2021

Cash Flows from Financing Activities:

Net increase in deposits

$

43,903

$

485,417

Repayment of term FHLB advances

( 1,170,000

)

( 2,257,796

)

Proceeds from term FHLB advances

1,045,000

1,955,000

Net increase (decrease) in other short-term borrowings

290,000

( 68,635

)

Net increase (decrease) in advance payments by borrowers for taxes

1,227

( 2,063

)

Repurchase and cancellation of common stock of Kearny Financial Corp.

( 95,967

)

( 80,567

)

Cancellation of shares repurchased on vesting to pay taxes

( 932

)

( 803

)

Exercise of stock options

-

373

Dividends paid

( 23,291

)

( 20,981

)

Net Cash Provided by Financing Activities

89,940

9,945

Net Decrease in Cash and Cash Equivalents

( 5,476

)

( 71,976

)

Cash and Cash Equivalents - Beginning

67,855

180,967

Cash and Cash Equivalents - Ending

$

62,379

$

108,991

Supplemental Disclosures of Cash Flows Information:

Cash paid during the period for:

Income taxes, net of refunds

$

9,497

$

13,675

Interest

$

21,666

$

41,649

Non-cash investing and financing activities:

Acquisition of other real estate owned in settlement of loans

$

703

$

-

Transfers from loans receivable to loans receivable held-for-sale

$

-

$

43,579

Fair value of assets acquired, net of cash and cash equivalents acquired

$

-

$

567,816

Fair value of liabilities assumed

$

-

$

523,926

See notes to unaudited consolidated financial statements.

- 7 -


KEARNY FINANCIAL CORP. AND SUBSIDIARIES

N OTES TO CONSOLIDATED FINANCIAL STATEMENTS (Unaudited)

1. SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Principles of Consolidation

The unaudited consolidated financial statements include the accounts of Kearny Financial Corp. (the “Company”), its wholly-owned subsidiary, Kearny Bank (the “Bank”) and the Bank’s wholly-owned subsidiary, CJB Investment Corp. The Company conducts its business principally through the Bank. Management prepared the unaudited consolidated financial statements in conformity with accounting principles generally accepted in the United States of America (“GAAP”), including the elimination of all significant inter-company accounts and transactions during consolidation.

Basis of Presentation

The accompanying unaudited consolidated financial statements were prepared in accordance with instructions for Form 10-Q and Regulation S-X and do not include the information or footnotes necessary for a complete presentation of financial condition, income, comprehensive income, changes in stockholders’ equity and cash flows in conformity with GAAP. However, in the opinion of management, all adjustments (consisting of normal recurring adjustments) necessary for a fair presentation of the unaudited consolidated financial statements have been included. The results of operations for the three months and nine months ended March 31, 2022 are not necessarily indicative of the results that may be expected for the entire fiscal year or any other period.

The data in the consolidated statement of financial condition for June 30, 2021 was derived from the Company’s 2021 Annual Report on Form 10-K. That data, along with the interim unaudited financial information presented in the consolidated statements of financial condition, income, comprehensive income, changes in stockholders’ equity and cash flows should be read in conjunction with the audited consolidated financial statements, including the notes thereto, included in the Company’s 2021 Annual Report on Form 10-K.

The accounting and reporting policies of the Company conform to U.S. GAAP and to general practice within the financial services industry. A discussion of these policies can be found in Note 1, Summary of Significant Accounting Policies, included in the Company’s 2021 Annual Report on Form 10-K. There have been no material changes to the Company’s significant accounting policies since June 30, 2021.

The Company has reclassified certain amounts in the prior period’s financial statements to conform to the current period’s presentation. Specifically, effective July 1, 2021, loan prepayment penalty income was reclassified to interest income on loans. Previously, loan prepayment penalty income was recorded within non-interest income. Interest income and non-interest income for all periods presented reflect this reclassification.

Update to Significant Accounting Policies

Allowance for Credit Losses (“ACL”) on Loans. In accordance with the ACL policy, the methodology is reviewed no less than annually. During the quarter ended September 30, 2021, the Company updated the econometric factors used in the determination of the probability of default for certain loan portfolio segments used in its ACL methodology for pooled loans. Econometric factors are selected based on the correlation of the factor to credit losses for each loan portfolio segment. Effective July 1, 2021, the primary econometric factor utilized in the determination of the probability of default for each loan portfolio segment is the national unemployment rate (“NUR”). Prior to July 1, 2021, NUR and gross domestic product (“GDP”) econometric factors were used in the determination of the probability of default for each loan portfolio segment.


- 8 -


2. SUBSEQUENT EVENTS

The Company has evaluated events and transactions occurring subsequent to the statement of financial condition date of March 31, 2022 , for items that should potentially be recognized or disclosed in these consolidated financial statements. The evaluation was conducted through the date this document was filed.

3. RECENT ACCOUNTING PRONOUNCEMENTS

In March 2022, the Financial Accounting Standards Board (the “FASB”) issued ASU 2022-02, “Financial Instruments-Credit Losses (Topic 326): Troubled Debt Restructurings and Vintage Disclosures” to improve the usefulness of information provided to investors about certain loan refinancings, restructurings and writeoffs. ASU 2022-02 eliminates the accounting guidance for troubled debt restructurings by creditors and enhances disclosure requirements for certain modifications made to borrowers experiencing financial difficulty. In addition, ASU 2022-02 requires public business entities to disclose current-period gross writeoffs for financing receivables and net investments in leases by year of origination in the vintage disclosures. For entities that have adopted ASU 2016-13, the amendments in ASU 2022-02 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is permitted if an entity has adopted ASU 2016-13, including adoption in an interim period. If an entity elects to early adopt the amendments in ASU 2022-02, the guidance should be applied as of the beginning of the fiscal year that includes the interim period. An entity may elect to early adopt the amendments about TDRs and related disclosure enhancements separately from the amendments related to vintage disclosures. The amendments in ASU 2022-02 should be applied prospectively, but for the amendments related to the recognition and measurement of TDRs, an entity has the option to apply a modified retrospective transition method that would result in a cumulative-effect adjustment to retained earnings in the period of adoption. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.

In March 2022, the FASB issued ASU 2022-01, “Derivatives and Hedging (Topic 815): Fair Value Hedging - Portfolio Layer Method” which clarifies the guidance in ASC 815 on fair value hedge accounting of interest rate risk for portfolios of financial assets. This ASU amends the guidance in ASU 2017-12 (released in August 2017) that, among other things, established the last-of-layer method to enable fair value hedge accounting for these portfolios to be more accessible. ASU 2022-01 expands the current last-of-layer method to allow multiple hedged layers of a single closed portfolio under this method. To reflect that expansion, the last-of-layer method is renamed the portfolio layer method. The scope of last-of-layer hedging will be expanded so that the portfolio layer method can be utilized for nonprepayable financial assets. In addition, ASU 2022-01 specifies eligible hedging instruments in a single-layer hedge, provides additional guidance on the accounting for and disclosure of hedge basis adjustments under the portfolio layer method, and specifies how hedge basis adjustments should be considered when determining credit losses for the assets included in the closed portfolio. For public business entities, the amendments in ASU 2022-01 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2022. Early adoption is permitted on any date on or after the issuance of ASU 2022-01 for any entity that has adopted the amendments in ASU 2017-12 for the corresponding period. The Company is currently evaluating the impact of the adoption of this ASU on its consolidated financial statements.

Adoption of New Accounting Standards

In December 2019, the FASB issued ASU 2019-12, “Income taxes (Topic 740): Simplifying the Accounting for Income Taxes”. ASU 2019-12 provides amendments intended to reduce the cost and complexity in accounting for income taxes while maintaining or improving the usefulness of the information provided to users of financial statements. ASU 2019-12 removes the following exceptions from ASC 740, Income Taxes: (i) exceptions to the incremental approach for intraperiod tax allocation; (ii) exceptions to accounting for basis differences when a foreign subsidiary becomes an equity method investment or a foreign equity method investment become a subsidiary; and (iii) exception in interim period income tax accounting for year-to-date losses that exceed anticipated losses. ASU 2019-12 provides the following amendments that simplify and improve guidance with Topic 740: (i) franchise taxes that are based partially on income; (ii) transactions that result in a step up in the tax basis of goodwill; (iii) separate financial statements of legal entities that are not subject to tax; (iv) enacted changes in tax laws in interim periods; and (v) employee stock ownership plans and investments in qualified affordable housing projects accounted for using the equity method. For public business entities, the amendments in the ASU 2019-12 are effective for fiscal years, and interim periods within those fiscal years, beginning after December 15, 2020. The Company adopted ASU 2019-12 in July 2021, and its adoption did not have a significant impact on the Company’s consolidated financial statements.

- 9 -


4. SECURITIES

The following tables present the amortized cost, gross unrealized gains and losses and estimated fair values for available for sale securities and the amortized cost, gross unrecognized gains and losses and estimated fair values for held to maturity securities as of the dates indicated:

March 31, 2022

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized
Losses

Allowance for
Credit Losses

Fair
Value

(In Thousands)

Available for sale:

Debt securities:

Obligations of state and political subdivisions

$

30,973

$

118

$

13

$

-

$

31,078

Asset-backed securities

230,997

375

1,788

-

229,584

Collateralized loan obligations

313,651

11

2,042

-

311,620

Corporate bonds

154,922

1,193

2,620

-

153,495

Total debt securities

730,543

1,697

6,463

-

725,777

Mortgage-backed securities:

Collateralized mortgage obligations (1)

8,265

1

270

-

7,996

Residential pass-through securities (1)

617,387

332

47,569

-

570,150

Commercial pass-through securities (1)

233,879

249

11,965

-

222,163

Total mortgage-backed securities

859,531

582

59,804

-

800,309

Total securities available for sale

$

1,590,074

$

2,279

$

66,267

$

-

$

1,526,086

(1)
Government-sponsored enterprises.

June 30, 2021

Amortized
Cost

Gross
Unrealized
Gains

Gross
Unrealized
Losses

Allowance for
Credit Losses

Fair
Value

(In Thousands)

Available for sale:

Debt securities:

Obligations of state and political subdivisions

$

33,800

$

803

$

-

$

-

$

34,603

Asset-backed securities

240,217

2,835

63

-

242,989

Collateralized loan obligations

189,873

177

170

-

189,880

Corporate bonds

155,622

2,802

73

-

158,351

Total debt securities

619,512

6,617

306

-

625,823

Mortgage-backed securities:

Collateralized mortgage obligations (1)

13,420

319

-

-

13,739

Residential pass-through securities (1)

744,196

7,443

7,148

-

744,491

Commercial pass-through securities (1)

289,725

5,738

2,652

-

292,811

Total mortgage-backed securities

1,047,341

13,500

9,800

-

1,051,041

Total securities available for sale

$

1,666,853

$

20,117

$

10,106

$

-

$

1,676,864

(1)
Government-sponsored enterprises .

- 10 -


March 31, 2022

Amortized
Cost

Gross
Unrecognized
Gains

Gross
Unrecognized
Losses

Allowance for
Credit Losses

Fair
Value

(In Thousands)

Held to maturity:

Debt securities:

Obligations of state and political subdivisions

$

23,546

$

122

$

24

$

-

$

23,644

Total debt securities

23,546

122

24

-

23,644

Mortgage-backed securities:

Residential pass-through securities (1)

86,017

-

3,989

-

82,028

Commercial pass-through securities (1)

12,290

-

945

-

11,345

Total mortgage-backed securities

98,307

-

4,934

-

93,373

Total securities held to maturity

$

121,853

$

122

$

4,958

$

-

$

117,017

(1)
Government-sponsored enterprises.

June 30, 2021

Amortized
Cost

Gross
Unrecognized
Gains

Gross
Unrecognized
Losses

Allowance for
Credit Losses

Fair
Value

(In Thousands)

Held to maturity:

Debt securities:

Obligations of state and political subdivisions

$

25,824

$

1,204

$

-

$

-

$

27,028

Total debt securities

25,824

1,204

-

-

27,028

Mortgage-backed securities:

Commercial pass-through securities (1)

12,314

268

-

-

12,582

Total mortgage-backed securities

12,314

268

-

-

12,582

Total securities held to maturity

$

38,138

$

1,472

$

-

$

-

$

39,610

(1)
Government-sponsored enterprises.

Excluding the balances of mortgage-backed securities, the following tables present the amortized cost and estimated fair values of debt securities available for sale and held to maturity, by contractual maturity, at March 31, 2022:

March 31, 2022

Amortized
Cost

Fair
Value

(In Thousands)

Available for sale debt securities:

Due in one year or less

$

1,970

$

1,971

Due after one year through five years

18,939

19,008

Due after five years through ten years

353,679

351,676

Due after ten years

355,955

353,122

Total

$

730,543

$

725,777

- 11 -


March 31, 2022

Amortized
Cost

Fair
Value

(In Thousands)

Held to maturity debt securities:

Due in one year or less

$

6,817

$

6,832

Due after one year through five years

15,026

15,084

Due after five years through ten years

1,703

1,728

Due after ten years

-

-

Total

$

23,546

$

23,644

Sales of securities available for sale were as follows for the periods presented below:

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

(In Thousands)

Available for sale securities sold:

Proceeds from sales of securities

$

-

$

-

$

-

$

44,842

Gross realized gains

$

-

$

-

$

-

$

800

Gross realized losses

-

-

-

( 385

)

Net gain on sales of securities

$

-

$

-

$

-

$

415

Gains resulting from calls of securities available for sale were as follows for the periods presented below:

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

(In Thousands)

Available for sale securities called:

Gross realized gains

$

3

$

18

$

4

$

39

Gross realized losses

-

-

-

-

Net gain on calls of securities

$

3

$

18

$

4

$

39

During the three months and nine months ended March 31, 2022 and 2021 , there were no gains or losses recognized on sales of securities held to maturity.

The carrying value of securities pledged for borrowings at the FHLB and other institutions, and securities pledged for public funds and other purposes, were as follows as of the dates presented below:

March 31,

June 30,

2022

2021

(In Thousands)

Securities pledged:

Pledged for borrowings at the FHLB of New York

$

155,868

$

170,120

Pledged to secure public funds on deposit

324,425

137,778

Pledged for potential borrowings at the Federal Reserve Bank of New York

372,968

274,076

Total carrying value of securities pledged

$

853,261

$

581,974

- 12 -


The following tables present the gross unrealized losses on securities and the estimated fair value of the related securities, aggregated by investment category and length of time that securities have been in a continuous unrealized loss position within the available for sale portfolio at March 31, 2022 and June 30, 2021:

March 31, 2022

Less than 12 Months

12 Months or More

Total

Fair
Value

Unrealized
Losses

Fair
Value

Unrealized
Losses

Number of Securities

Fair
Value

Unrealized
Losses

(Dollars in Thousands)

Securities Available for Sale:

Obligations of state and political
subdivisions

$

2,303

$

13

$

-

$

-

8

$

2,303

$

13

Asset-backed securities

180,827

1,788

-

-

15

180,827

1,788

Collateralized loan obligations

226,513

1,780

52,851

262

22

279,364

2,042

Corporate bonds

75,909

2,495

3,875

125

16

79,784

2,620

Collateralized mortgage obligations

6,819

270

-

-

5

6,819

270

Commercial pass-through securities

48,811

1,147

113,569

10,818

15

162,380

11,965

Residential pass-through securities

237,063

14,376

302,905

33,193

66

539,968

47,569

Total

$

778,245

$

21,869

$

473,200

$

44,398

147

$

1,251,445

$

66,267

June 30, 2021

Less than 12 Months

12 Months or More

Total

Fair
Value

Unrealized
Losses

Fair
Value

Unrealized
Losses

Number of Securities

Fair
Value

Unrealized
Losses

(Dollars in Thousands)

Securities Available for Sale:

Asset-backed securities

$

12,159

$

63

$

-

$

-

2

$

12,159

$

63

Collateralized loan obligations

36,741

9

58,605

161

8

95,346

170

Corporate bonds

15,952

73

-

-

4

15,952

73

Commercial pass-through securities

145,055

2,652

-

-

7

145,055

2,652

Residential pass-through securities

424,112

7,148

-

-

10

424,112

7,148

Total

$

634,019

$

9,945

$

58,605

$

161

31

$

692,624

$

10,106

The following table presents the gross unrecognized losses on securities and the estimated fair value of the related securities, aggregated by investment category and length of time that securities have been in a continuous unrecognized loss position within the held to maturity portfolio at March 31, 2022:

March 31, 2022

Less than 12 Months

12 Months or More

Total

Fair
Value

Unrecognized
Losses

Fair
Value

Unrecognized
Losses

Number of Securities

Fair
Value

Unrecognized
Losses

(Dollars in Thousands)

Securities Held to Maturity:

Obligations of state and political
subdivisions

$

4,901

$

24

$

-

$

-

8

$

4,901

$

24

Commercial pass-through
securities

11,345

945

-

-

1

11,345

945

Residential pass-through
securities

82,028

3,989

-

-

8

82,028

3,989

Total

$

98,274

$

4,958

$

-

$

-

17

$

98,274

$

4,958

At June 30, 2021 , there were no held to maturity securities with unrecognized losses.

- 13 -


Available for sale securities are evaluated to determine if a decline in fair value below the amortized cost basis has resulted from a credit loss or from other factors. An impairment related to credit factors would be recorded through an allowance for credit losses. The allowance is limited to the amount by which the security’s amortized cost basis exceeds the fair value. An impairment that has not been recorded through an allowance for credit losses shall be recorded through other comprehensive income, net of applicable taxes. Investment securities will be written down to fair value through the consolidated statement of income if management intends to sell, or may be required to sell, the securities before they recover in value. The issuers of these securities continue to make timely principal and interest payments and none of these securities were past due or were placed in nonaccrual status at March 31, 2022 . Management believes that the unrealized losses on these securities are a function of changes in market interest rates and credit spreads, not changes in credit quality. No allowance for credit losses was recorded at March 31, 2022 on available for sale securities.

At March 31, 2022, the held to maturity securities portfolio consists of agency mortgage-backed securities and obligations of state and political subdivisions. The mortgage-backed securities are issued by U.S. government agencies and are implicitly guaranteed by the U.S. government. The obligations of state and political subdivisions in the portfolio are highly rated by major rating agencies and have a long history of no credit losses. The Company regularly monitors the obligations of state and political subdivisions sector of the market and reviews collectability including such factors as the financial condition of the issuers as well as credit ratings in effect as of the reporting period. No allowance for credit losses was recorded at March 31, 2022 on held to maturity securities.

5 . LOANS RECEIVABLE

The following table sets forth the composition of the Company’s loan portfolio at March 31, 2022 and June 30, 2021:

March 31,

June 30,

2022

2021

(In Thousands)

Commercial loans:

Multi-family mortgage

$

2,076,003

$

2,039,260

Nonresidential mortgage

1,085,988

1,079,444

Commercial business

169,551

168,951

Construction

121,137

93,804

Total commercial loans

3,452,679

3,381,459

One- to four-family residential mortgage

1,527,980

1,447,721

Consumer loans:

Home equity loans

41,501

47,871

Other consumer

2,755

3,259

Total consumer loans

44,256

51,130

Total loans

5,024,915

4,880,310

Unaccreted yield adjustments

( 21,714

)

( 28,916

)

Total loans receivable, net of yield adjustments

$

5,003,201

$

4,851,394

- 14 -


Past Due Loans

Past due status is based on the contractual payment terms of the loans. The following tables present the payment status of past due loans as of March 31, 2022 and June 30, 2021, by loan segment:

Payment Status

March 31, 2022

30-59 Days

60-89 Days

90 Days and Over

Total Past Due

Current

Total

(In Thousands)

Multi-family mortgage

$

-

$

-

$

28,197

$

28,197

$

2,047,806

$

2,076,003

Nonresidential mortgage

2,101

-

25,283

27,384

1,058,604

1,085,988

Commercial business

-

64

281

345

169,206

169,551

Construction

-

-

-

-

121,137

121,137

One- to four-family
residential mortgage

3,410

520

2,968

6,898

1,521,082

1,527,980

Home equity loans

25

4

59

88

41,413

41,501

Other consumer

-

-

-

-

2,755

2,755

Total loans

$

5,536

$

588

$

56,788

$

62,912

$

4,962,003

$

5,024,915

Payment Status

June 30, 2021

30-59 Days

60-89 Days

90 Days and Over

Total Past Due

Current

Total

(In Thousands)

Multi-family mortgage

$

-

$

-

$

16,094

$

16,094

$

2,023,166

$

2,039,260

Nonresidential mortgage

-

-

32,891

32,891

1,046,553

1,079,444

Commercial business

-

-

401

401

168,550

168,951

Construction

-

-

-

-

93,804

93,804

One- to four-family
residential mortgage

382

2,734

5,104

8,220

1,439,501

1,447,721

Home equity loans

6

5

32

43

47,828

47,871

Other consumer

1

-

-

1

3,258

3,259

Total loans

$

389

$

2,739

$

54,522

$

57,650

$

4,822,660

$

4,880,310

Nonperforming Loans

Loans are generally placed on nonaccrual status when contractual payments become 90 or more days past due or when the Company does not expect to receive all principal and interest payments owed substantially in accordance with the terms of the loan agreement, regardless of past due status. Loans that become 90 days past due, but are well secured and in the process of collection, may remain on accrual status. Nonaccrual loans are generally returned to accrual status when all payments due are brought current and the Company expects to receive all remaining principal and interest payments owed substantially in accordance with the terms of the loan agreement. Payments received in cash on nonaccrual loans, including both the principal and interest portions of those payments, are generally applied to reduce the carrying value of the loan. The Company did not recognize interest income on non-accrual loans during the three months and nine months ended March 31, 2022 and 2021.

- 15 -


The following tables present information relating to the Company’s nonperforming loans as of March 31, 2022 and June 30, 2021:

Performance Status

March 31, 2022

90 Days and Over Past Due Accruing

Nonaccrual Loans with Allowance for Credit Losses

Nonaccrual Loans with no Allowance for Credit Losses

Total Nonperforming

Performing

Total

(In Thousands)

Multi-family mortgage

$

-

$

11,369

$

28,646

$

40,015

$

2,035,988

$

2,076,003

Nonresidential mortgage

-

3,667

24,523

28,190

1,057,798

1,085,988

Commercial business

-

63

430

493

169,058

169,551

Construction

-

-

1,791

1,791

119,346

121,137

One- to four-family
residential mortgage

-

4,376

4,241

8,617

1,519,363

1,527,980

Home equity loans

-

313

1,176

1,489

40,012

41,501

Other consumer

-

-

-

-

2,755

2,755

Total loans

$

-

$

19,788

$

60,807

$

80,595

$

4,944,320

$

5,024,915

Performance Status

June 30, 2021

90 Days and Over Past Due Accruing

Nonaccrual Loans with Allowance for Credit Losses

Nonaccrual Loans with no Allowance for Credit Losses

Total Nonperforming

Performing

Total

(In Thousands)

Multi-family mortgage

$

-

$

8,300

$

10,226

$

18,526

$

2,020,734

$

2,039,260

Nonresidential mortgage

-

12,612

24,575

37,187

1,042,257

1,079,444

Commercial business

-

236

676

912

168,039

168,951

Construction

-

-

2,228

2,228

91,576

93,804

One- to four-family
residential mortgage

-

7,422

11,748

19,170

1,428,551

1,447,721

Home equity loans

-

452

1,292

1,744

46,127

47,871

Other consumer

-

-

-

-

3,259

3,259

Total loans

$

-

$

29,022

$

50,745

$

79,767

$

4,800,543

$

4,880,310

Troubled Debt Restructurings (“TDRs”)

TDRs are loans where the Company has modified the contractual terms of the loan as a result of the financial condition of the borrower. Subsequent to their modification, TDRs are placed on non-accrual until such time as satisfactory payment performance has been demonstrated, at which time the loan may be returned to accrual status. On a case-by-case basis, the Company may agree to modify the contractual terms of a loan to assist a borrower who may be experiencing financial difficulty, as well as to preserve the Company’s position in the loan. If the borrower is experiencing financial difficulties and a concession has been made at the time of such modification, the loan is classified as a TDR. The Company had TDRs totaling $ 31.7 million and $ 17.8 million as of March 31, 2022 and June 30, 2021, respectively. The allowance for credit losses associated with the TDRs presented in the tables below totaled $ 672,000 an d $ 256,000 as of March 31, 2022 and June 30, 2021, respectively. As of March 31, 2022, there were no significant commitments to lend additional funds to borrowers whose loans had been restructured in a TDR.

- 16 -


The following tables present total TDR loans at March 31, 2022 and June 30, 2021:

March 31, 2022

Accrual

Non-accrual

Total

# of Loans

Amount

# of Loans

Amount

# of Loans

Amount

(Dollars In Thousands)

Commercial loans:

Multi-family mortgage

-

$

-

3

$

14,605

3

$

14,605

Nonresidential mortgage

4

400

2

1,646

6

2,046

Commercial business

5

3,704

3

325

8

4,029

Construction

-

-

1

1,791

1

1,791

Total commercial loans

9

4,104

9

18,367

18

22,471

One- to four-family residential
mortgage

29

4,270

15

3,392

44

7,662

Consumer loans:

Home equity loans

5

170

2

1,396

7

1,566

Total

43

$

8,544

26

$

23,155

69

$

31,699

June 30, 2021

Accrual

Non-accrual

Total

# of Loans

Amount

# of Loans

Amount

# of Loans

Amount

(Dollars In Thousands)

Commercial loans:

Multi-family mortgage

-

$

-

1

$

2,896

1

$

2,896

Nonresidential mortgage

1

105

6

2,275

7

2,380

Commercial business

3

3,755

6

693

9

4,448

Construction

-

-

1

2,228

1

2,228

Total commercial loans

4

3,860

14

8,092

18

11,952

One- to four-family residential
mortgage

18

2,216

20

3,405

38

5,621

Consumer loans:

Home equity loans

4

159

3

68

7

227

Total

26

$

6,235

37

$

11,565

63

$

17,800

The following tables present information regarding troubled debt restructurings that occurred during the three months and nine months ended March 31, 2022 and 2021:

Three Months Ended March 31, 2022

Nine Months Ended March 31, 2022

# of Loans

Pre-
modification
Recorded
Investment

Post-
modification
Recorded
Investment

# of Loans

Pre-
modification
Recorded
Investment

Post-
modification
Recorded
Investment

(Dollars In Thousands)

Multi-family mortgage

1

$

9,104

$

9,101

2

$

12,091

$

12,073

One- to four-family residential
mortgage

8

2,953

2,965

10

3,214

3,226

Home equity loans

2

1,477

1,477

2

1,477

1,477

Total

11

$

13,534

$

13,543

14

$

16,782

$

16,776

Three Months Ended March 31, 2021

Nine Months Ended March 31, 2021

# of Loans

Pre-
modification
Recorded
Investment

Post-
modification
Recorded
Investment

# of Loans

Pre-
modification
Recorded
Investment

Post-
modification
Recorded
Investment

(Dollars In Thousands)

One- to four-family residential
mortgage

-

$

-

$

-

1

$

309

$

308

Home equity loans

1

24

24

1

24

24

Total

1

$

24

$

24

2

$

333

$

332

- 17 -


During the three months and nine months ended March 31, 2022 and 2021 , there were no charge-offs related to TDRs. During the three months and nine months ended March 31, 2022 and 2021 , there were no defaults of TDRs.

Loan modifications generally involve a reduction in interest rates and/or extension of maturity dates and also may include step up interest rates in their modified terms which will impact their weighted average yield in the future. The loans which qualified as TDRs during the three months and nine months ended March 31, 2022 and 2021, capitalized prior past due amounts and modified the repayment terms.

In March 2020, various regulatory agencies, including the Board of Governors of the Federal Reserve System (the “FRB”) and the Federal Deposit Insurance Corporation (the “FDIC”), issued an interagency statement on loan modifications and reporting for financial institutions working with customers affected by COVID-19. The interagency statement was effective immediately and impacted accounting for loan modifications. The agencies confirmed with the staff of the FASB that short-term modifications, made on a good faith basis in response to COVID-19 to borrowers who were current prior to any relief, were not to be considered TDRs. This included short-term modifications such as payment deferrals, fee waivers, extension of repayment terms, or other delays in payment that were insignificant. Provisions of the Coronavirus Aid, Relief, and Economic Security Act (the “CARES Act”) largely mirrored the provisions of the interagency statement, providing that modified loans were not to be considered TDRs if they were performing at December 31, 2019 and other considerations set forth in the interagency statements were met. Borrowers considered current are those that were less than 30 days past due at the time a modification program was implemented or at December 31, 2019.

On December 27, 2020, the 2021 Consolidated Appropriations Act was signed into law. The $ 900 billion relief package included legislation that extended certain relief provisions of the CARES Act that were set to expire on December 31, 2020 . The relief expired on January 1, 2022. As of March 31, 2022, the Company did not have any no n-TDR loan modifications granted under the CARES Act .

Individually Analyzed Loans

Effective July 1, 2020, individually analyze d loans include loans which do not share similar risk characteristics with other loans. TDRs will generally be evaluated for individual impairment, however, after a period of sustained repayment performance which permits the credit to be returned to accrual status, a TDR would generally be removed from individual impairment analysis and returned to its corresponding pool. As of March 31, 2022, the carrying value of individually analyzed loans totaled $ 82.7 million , of which $ 65.1 million were considered collateral dependent.

For collateral dependent loans where management has determined that foreclosure of the collateral is probable, or where the borrower is experiencing financial difficulty and repayment of the loan is to be provided substantially through the operation or sale of the collateral, the ACL is measured based on the difference between the fair value of the collateral, less costs to sell, and the amortized cost basis of the loan as of the measurement date. See Note 12 for additional disclosure regarding fair value of individually analyzed collateral dependent loans.

- 18 -


The following table presents the carrying value and related allowance of collateral dependent individually analyzed loans at the dates indicated:

March 31, 2022

June 30, 2021

Carrying Value

Related Allowance

Carrying Value

Related Allowance

(In Thousands)

Commercial loans:

Multi-family mortgage

$

31,078

$

661

$

18,526

$

1,368

Nonresidential mortgage (1)

27,384

119

32,891

4,724

Commercial business (2)

176

-

183

-

Construction

1,791

-

-

-

Total commercial loans

60,429

780

51,600

6,092

One- to four-family residential mortgage (3)

4,581

196

7,612

420

Consumer loans:

Home equity loans (3)

59

-

31

-

Total

$

65,069

$

976

$

59,243

$

6,512

(1)
Secured by income-producing nonresidential property.
(2)
Secured by business assets.
(3)
Secured by one- to four-family residential properties.

Credit Quality Indicators

The Company categorizes loans into risk categories based on relevant information about the ability of borrowers to service their debt such as: current financial information, historical payment experience, credit documentation, public information, and current economic trends, among other factors. The Company analyzes loans individually to classify the loans as to credit risk. The Company uses the following definitions for risk ratings:

Pass – Loans that are well protected by the current net worth and paying capacity of the obligor (or guarantors, if any) or by the fair value, less cost to acquire and sell, of any underlying collateral in a timely manner.

Special Mention – Loans which do not currently expose the Company to a sufficient degree of risk to warrant an adverse classification but have some credit deficiencies or other potential weaknesses.

Substandard – Loans which are inadequately protected by the paying capacity and net worth of the obligor or the collateral pledged, if any. Substandard assets include those characterized by the distinct possibility that the Company will sustain some loss if the deficiencies are not corrected.

Doubtful – Loans which have all of the weaknesses inherent in those classified as Substandard, with the added characteristic that the weaknesses present make collection or liquidation in full highly questionable and improbable, on the basis of currently existing facts, conditions and values.

Loss – Loans which are considered uncollectible or of so little value that their continuance as assets is not warranted.

- 19 -


The following table presents the risk category of loans as of March 31, 2022 by loan segment and vintage year:

Term Loans by Origination Year for Fiscal Years ended June 30,

2022

2021

2020

2019

2018

Prior

Revolving Loans

Total

(In Thousands)

Multi-family mortgage:

Pass

$

520,269

$

263,316

$

216,072

$

256,541

$

252,909

$

500,758

$

-

$

2,009,865

Special Mention

-

-

-

16,370

4,994

4,759

-

26,123

Substandard

-

-

-

10,182

2,788

27,045

-

40,015

Doubtful

-

-

-

-

-

-

-

-

Total multi-family mortgage

520,269

263,316

216,072

283,093

260,691

532,562

-

2,076,003

Nonresidential mortgage:

Pass

201,205

86,212

64,161

37,706

51,884

569,499

6,087

1,016,754

Special Mention

-

-

-

23,364

4,070

9,249

-

36,683

Substandard

-

724

-

933

-

30,894

-

32,551

Doubtful

-

-

-

-

-

-

-

-

Total nonresidential mortgage

201,205

86,936

64,161

62,003

55,954

609,642

6,087

1,085,988

Commercial business:

Pass

36,918

39,481

12,441

3,961

9,147

7,370

54,513

163,831

Special Mention

-

-

65

189

2,173

895

216

3,538

Substandard

-

39

230

-

1,422

285

58

2,034

Doubtful

-

-

-

-

-

145

3

148

Total commercial business

36,918

39,520

12,736

4,150

12,742

8,695

54,790

169,551

Construction loans:

Pass

7,868

85,564

9,492

3,058

6,513

1,117

5,735

119,347

Special Mention

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

1,790

-

1,790

Doubtful

-

-

-

-

-

-

-

-

Total construction loans

7,868

85,564

9,492

3,058

6,513

2,907

5,735

121,137

Residential mortgage:

Pass

312,625

531,111

90,576

53,262

56,834

464,738

375

1,509,521

Special Mention

-

-

-

1,213

-

439

-

1,652

Substandard

-

-

1,704

83

-

15,020

-

16,807

Doubtful

-

-

-

-

-

-

-

-

Total residential mortgage

312,625

531,111

92,280

54,558

56,834

480,197

375

1,527,980

Home equity loans:

Pass

1,759

715

1,744

3,245

2,125

7,552

22,156

39,296

Special Mention

-

-

-

-

-

265

-

265

Substandard

-

-

-

124

-

1,816

-

1,940

Doubtful

-

-

-

-

-

-

-

-

Total home equity loans

1,759

715

1,744

3,369

2,125

9,633

22,156

41,501

Other consumer loans

Pass

281

324

477

398

247

913

40

2,680

Special Mention

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

-

-

-

Doubtful

-

-

-

-

-

-

75

75

Other consumer loans

281

324

477

398

247

913

115

2,755

Total loans

$

1,080,925

$

1,007,486

$

396,962

$

410,629

$

395,106

$

1,644,549

$

89,258

$

5,024,915

- 20 -


The following table presents the risk category of loans as of June 30, 2021 by loan segment and vintage year:

Term Loans by Origination Year for Fiscal Years ended June 30,

2021

2020

2019

2018

2017

Prior

Revolving Loans

Total

(In Thousands)

Multi-family mortgage:

Pass

$

281,402

$

257,970

$

374,871

$

341,304

$

343,370

$

374,909

$

-

$

1,973,826

Special Mention

-

-

26,974

5,079

4,834

1,054

-

37,941

Substandard

-

-

-

2,896

13,198

11,399

-

27,493

Doubtful

-

-

-

-

-

-

-

-

Total multi-family mortgage

281,402

257,970

401,845

349,279

361,402

387,362

-

2,039,260

Nonresidential mortgage:

Pass

99,602

77,146

56,435

64,616

254,940

441,696

6,150

1,000,585

Special Mention

-

-

23,520

4,146

8,801

4,513

-

40,980

Substandard

743

-

-

4,934

20,602

11,600

-

37,879

Doubtful

-

-

-

-

-

-

-

-

Total nonresidential mortgage

100,345

77,146

79,955

73,696

284,343

457,809

6,150

1,079,444

Commercial business:

Pass

44,514

18,988

4,701

12,654

3,322

12,892

65,657

162,728

Special Mention

-

-

-

2,304

945

12

461

3,722

Substandard

41

76

160

1,474

132

189

-

2,072

Doubtful

-

-

-

-

-

420

9

429

Total commercial business

44,555

19,064

4,861

16,432

4,399

13,513

66,127

168,951

Construction loans:

Pass

40,332

17,404

11,203

13,860

1,641

1,382

5,735

91,557

Special Mention

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

2,247

-

2,247

Doubtful

-

-

-

-

-

-

-

-

Total construction loans

40,332

17,404

11,203

13,860

1,641

3,629

5,735

93,804

Residential mortgage:

Pass

560,543

124,606

69,917

74,754

119,238

472,587

375

1,422,020

Special Mention

-

-

1,233

-

-

712

-

1,945

Substandard

-

1,040

671

511

1,468

20,066

-

23,756

Doubtful

-

-

-

-

-

-

-

-

Total residential mortgage

560,543

125,646

71,821

75,265

120,706

493,365

375

1,447,721

Home equity loans:

Pass

834

2,508

4,585

2,778

2,241

7,798

24,788

45,532

Special Mention

-

-

-

-

-

393

-

393

Substandard

-

-

-

-

11

1,935

-

1,946

Doubtful

-

-

-

-

-

-

-

-

Total home equity loans

834

2,508

4,585

2,778

2,252

10,126

24,788

47,871

Other consumer loans

Pass

550

517

633

256

127

1,044

44

3,171

Special Mention

-

-

-

-

-

-

-

-

Substandard

-

-

-

-

-

-

1

1

Doubtful

-

-

-

-

-

-

87

87

Other consumer loans

550

517

633

256

127

1,044

132

3,259

Total loans

$

1,028,561

$

500,255

$

574,903

$

531,566

$

774,870

$

1,366,848

$

103,307

$

4,880,310

Residential Mortgage Loans in Foreclosure

The Company may obtain physical possession of one- to four-family real estate collateralizing a residential mortgage loan via foreclosure or through an in-substance repossession. As of March 31, 2022, the Company hel d two single-family properties in other real estate owned with an aggregate carrying value of $ 401,000 that were acquired through foreclosure on residential mortgage loans. As of that same date, the Company held eight residential mortgage loans with aggregate carrying values totaling $ 1.6 million which were in the process of foreclosure. As of June 30, 2021 , the Company held one single-family property in other real estate owned with an aggregate carrying value of $ 178,000 that was acquired through a foreclosure on a residential mortgage loan. As of that same date, the Company held 11 residential mortgage loans with aggregate carrying values totaling $ 2.1 million which were in the process of foreclosure.

New Jersey’s moratorium on evictions ended on December 31, 2021. Under New Jersey’s new eviction protections for people under certain income levels, no evictions may occur now or in the future based on rent due during the time period of March 1, 2020 through August 31, 2021, for certain moderate income families, or March 1, 2020 through December 31, 2021 for certain low income families. The moratorium on home foreclosures ended on November 15, 2021, for all income levels. This included landlords facing foreclosure who currently have tenants. New York’ s moratorium on evictions for tenants who have endured COVID-related hardships and on foreclosures ended on January 15, 2022. As a result, the Company has resumed residential property foreclosure sales and evictions. Eviction laws may be subject to legal challenges and could change based on the results of court proceedings.

- 21 -


6. ALLOWANCE FOR CREDIT LOSSES

Adoption of Topic 326

On July 1, 2020, the Company adopted ASU 2016-13, “Financial Instruments – Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments”, which replaces the incurred loss methodology with an expected loss methodology, referred to as the “CECL” methodology.

Allowance for Credit Losses on Loans Receivable

The following tables present the balance of the allowance for credit losses at March 31, 2022 and June 30, 2021. For the three months and nine months ended March 31, 2022 and 2021, the balance of the allowance for credit losses is based on the CECL methodology, as noted above. The tables identify the valuation allowances attributable to specifically identified impairments on individually evaluated loans, including those acquired with deteriorated credit quality, as well as valuation allowances for impairments on loans evaluated collectively. The tables include the underlying balance of loans receivable applicable to each category as of those dates.

Allowance for Credit Losses

March 31, 2022

Loans
acquired with
deteriorated
credit quality
individually
analyzed

Loans
acquired with
deteriorated
credit quality
collectively
evaluated

Loans individually
analyzed

Loans collectively
evaluated

Total allowance for credit losses

(In Thousands)

Multi-family mortgage

$

-

$

-

$

1,083

$

23,144

$

24,227

Nonresidential mortgage

-

363

119

8,557

9,039

Commercial business

-

11

6

1,708

1,725

Construction

-

-

-

1,274

1,274

One- to four-family
residential mortgage

-

242

278

6,758

7,278

Home equity loans

22

-

-

214

236

Other consumer

-

-

-

81

81

Total loans

$

22

$

616

$

1,486

$

41,736

$

43,860

Balance of Loans Receivable

March 31, 2022

Loans
acquired with
deteriorated
credit quality
individually
analyzed

Loans
acquired with
deteriorated
credit quality
collectively
evaluated

Loans individually
analyzed

Loans collectively
evaluated

Total loans

(In Thousands)

Multi-family mortgage

$

-

$

-

$

40,015

$

2,035,988

$

2,076,003

Nonresidential mortgage

381

13,179

29,911

1,042,517

1,085,988

Commercial business

176

1,267

317

167,791

169,551

Construction

-

5,735

1,791

113,611

121,137

One- to four-family
residential mortgage

230

6,666

8,386

1,512,698

1,527,980

Home equity loans

342

60

1,147

39,952

41,501

Other consumer

-

-

-

2,755

2,755

Total loans

$

1,129

$

26,907

$

81,567

$

4,915,312

$

5,024,915

Unaccreted yield adjustments

( 21,714

)

Loans receivable, net of
yield adjustments

$

5,003,201

- 22 -


Allowance for Credit Losses

June 30, 2021

Loans
acquired with
deteriorated
credit quality
individually
analyzed

Loans
acquired with
deteriorated
credit quality
collectively
evaluated

Loans individually
analyzed

Loans collectively
evaluated

Total allowance for credit losses

(In Thousands)

Multi-family mortgage

$

-

$

155

$

1,368

$

26,927

$

28,450

Nonresidential mortgage

2,700

692

2,025

10,826

16,243

Commercial business

-

15

33

2,038

2,086

Construction

-

49

-

1,121

1,170

One- to four-family
residential mortgage

122

204

447

8,974

9,747

Home equity loans

21

1

1

410

433

Other consumer

-

-

-

36

36

Total loans

$

2,843

$

1,116

$

3,874

$

50,332

$

58,165

Balance of Loans Receivable

June 30, 2021

Loans
acquired with
deteriorated
credit quality
individually
analyzed

Loans
acquired with
deteriorated
credit quality
collectively
evaluated

Loans individually
analyzed

Loans collectively
evaluated

Total loans

(In Thousands)

Multi-family mortgage

$

-

$

5,599

$

18,526

$

2,015,135

$

2,039,260

Nonresidential mortgage

6,519

25,844

30,668

1,016,413

1,079,444

Commercial business

183

2,533

729

165,506

168,951

Construction

-

12,970

2,228

78,606

93,804

One- to four-family
residential mortgage

3,617

4,785

15,553

1,423,766

1,447,721

Home equity loans

380

65

1,364

46,062

47,871

Other consumer

-

-

-

3,259

3,259

Total loans

$

10,699

$

51,796

$

69,068

$

4,748,747

$

4,880,310

Unaccreted yield adjustments

( 28,916

)

Loans receivable, net of
yield adjustments

$

4,851,394

- 23 -


The following tables present the activity in the allowance for credit losses on loans for the three months and nine months ended March 31, 2022 and 2021.

Changes in the Allowance for Credit Losses

Three Months Ended March 31, 2022

Balance at
December 31, 2021

Charge-offs

Recoveries

(Reversal of)
provision for
credit losses

Balance at
March 31, 2022

(In Thousands)

Multi-family mortgage

$

25,795

$

-

$

-

$

( 1,568

)

$

24,227

Nonresidential mortgage

10,078

( 441

)

-

( 598

)

9,039

Commercial business

1,903

-

4

( 182

)

1,725

Construction

1,441

-

-

( 167

)

1,274

One- to four-family
residential mortgage

8,601

-

-

( 1,323

)

7,278

Home equity loans

308

-

-

( 72

)

236

Other consumer

90

-

1

( 10

)

81

Total loans

$

48,216

$

( 441

)

$

5

$

( 3,920

)

$

43,860

Changes in the Allowance for Credit Losses

Nine Months Ended March 31, 2022

Balance at
June 30, 2021

Charge-offs

Recoveries

(Reversal of)
provision for
credit losses

Balance at
March 31, 2022

(In Thousands)

Multi-family mortgage

$

28,450

$

( 104

)

$

-

$

( 4,119

)

$

24,227

Nonresidential mortgage

16,243

( 2,538

)

-

( 4,666

)

9,039

Commercial business

2,086

( 175

)

105

( 291

)

1,725

Construction

1,170

-

-

104

1,274

One- to four-family
residential mortgage

9,747

-

147

( 2,616

)

7,278

Home equity loans

433

-

1

( 198

)

236

Other consumer

36

( 2

)

1

46

81

Total loans

$

58,165

$

( 2,819

)

$

254

$

( 11,740

)

$

43,860

- 24 -


Changes in the Allowance for Credit Losses

Three Months Ended March 31, 2021

Balance at
December 31, 2020

Charge-offs

Recoveries

(Reversal of)
provision for
credit losses

Balance at
March 31, 2021

(In Thousands)

Multi-family mortgage

$

29,500

$

-

$

-

$

( 514

)

$

28,986

Nonresidential mortgage

15,933

( 9

)

-

4,053

19,977

Commercial business

3,348

( 738

)

2

( 86

)

2,526

Construction

1,205

-

-

40

1,245

One- to four-family
residential mortgage

12,625

-

2

( 2,249

)

10,378

Home equity loans

725

-

-

( 117

)

608

Other consumer

50

( 9

)

2

( 1

)

42

Total loans

$

63,386

$

( 756

)

$

6

$

1,126

$

63,762

Changes in the Allowance for Credit Losses

Nine Months Ended March 31, 2021

Balance at June 30, 2020 (prior to
adoption of ASC 326):

Impact of adopting
Topic 326

Charge-offs

Recoveries

Initial allowance on PCD loans

(Reversal of)
provision for
credit losses

Balance at
March 31, 2021

(In Thousands)

Multi-family mortgage

$

20,916

$

8,408

$

-

$

-

$

250

$

( 588

)

$

28,986

Nonresidential mortgage

8,763

2,390

( 75

)

-

1,720

7,179

19,977

Commercial business

1,926

( 421

)

( 802

)

7

1,007

809

2,526

Construction

236

80

-

-

99

830

1,245

One- to four-family
residential mortgage

4,860

9,106

( 13

)

2

720

( 4,297

)

10,378

Home equity loans

568

92

( 32

)

-

105

( 125

)

608

Other consumer

58

( 15

)

( 22

)

9

-

12

42

Total loans

$

37,327

$

19,640

$

( 944

)

$

18

$

3,901

$

3,820

$

63,762

Allowance for Credit Losses on Off Balance Sheet Commitments

The following table presents the activity in the allowance for credit losses on off balance sheet commitments recorded in other non-interest expense for the three months and nine months ended March 31, 2022 and 2021:

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

(In Thousands)

(In Thousands)

Balance at beginning of the period

$

1,148

$

1,058

$

1,708

$

-

Impact of adopting Topic 326 (1)

-

-

-

536

(Reversal of) provision for credit losses

( 208

)

207

( 768

)

729

Balance at end of the period

$

940

$

1,265

$

940

$

1,265

(1)
Adoption of CECL accounting standard effective July 1, 2020 .

- 25 -


7 . DEPOSITS

Deposits are summarized as follows:

March 31,

June 30,

2022

2021

(In Thousands)

Non-interest-bearing demand

$

621,954

$

593,718

Interest-bearing demand

2,154,488

1,902,478

Savings

1,088,974

1,111,364

Certificates of deposits

1,663,246

1,877,746

Total deposits

$

5,528,662

$

5,485,306

8. BORROWINGS

Borrowings at March 31, 2022 and June 30, 2021 consisted of the following:

March 31,

June 30,

2022

2021

(In Thousands)

FHLB advances

$

541,220

$

665,876

Overnight borrowings

310,000

20,000

Total borrowings

$

851,220

$

685,876

Fixed rate advances from the FHLB of New York mature as follows:

March 31, 2022

June 30, 2021

Balance

Weighted
Average
Interest Rate

Balance

Weighted
Average
Interest Rate

(Dollars in Thousands)

By remaining period to maturity:

Less than one year

$

265,000

0.63

%

$

390,000

0.33

%

One to two years

145,000

3.04

145,000

3.04

Two to three years

103,500

2.65

22,500

2.63

Three to four years

29,000

2.77

103,500

2.68

Four to five years

-

-

6,500

2.82

Greater than five years

-

-

-

-

Total advances

542,500

1.77

%

667,500

1.38

%

Unamortized fair value adjustments

( 1,280

)

( 1,624

)

Total advances, net of fair value adjustments

$

541,220

$

665,876

At March 31, 2022, FHLB advances were collateralized by the FHLB capital stock owned by the Bank and mortgage loans and securities with carrying values totaling approximatel y $ 3.44 billion and $ 155.9 million , respectively. At June 30, 2021, FHLB advances were collateralized by the FHLB capital stock owned by the Bank and mortgage loans and securities with carrying values totaling approximately $ 3.27 billion and $ 170.1 million , respectively.

- 26 -


9. DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES

Risk Management Objective of Using Derivatives

The Company uses various financial instruments, including derivatives, to manage its exposure to interest rate risk. The Company’s derivative financial instruments are used to manage differences in the amount, timing, and duration of the Company’s known or expected cash receipts and its known or expected cash payments principally related to specific wholesale funding positions.

Fair Values of Derivative Instruments on the Statement of Financial Condition

The tables below present the fair value of the Company’s derivative financial instruments as well as their classification on the Statement of Financial Condition as of March 31, 2022 and June 30, 2021:

March 31, 2022

Asset Derivatives

Liability Derivatives

Location

Fair Value

Location

Fair Value

(In Thousands)

Derivatives designated as hedging instruments:

Interest rate contracts

Other assets

$

34,007

Other liabilities

$

-

Total

$

34,007

$

-

June 30, 2021

Asset Derivatives

Liability Derivatives

Location

Fair Value

Location

Fair Value

(In Thousands)

Derivatives designated as hedging instruments:

Interest rate contracts

Other assets

$

1,832

Other liabilities

$

673

Total

$

1,832

$

673

Cash Flow Hedges of Interest Rate Risk

The Company’s objectives in using derivatives are primarily to add stability to interest expense and to manage its exposure to interest rate movements. To accomplish this objective, the Company has entered into interest rate swaps and caps as part of its interest rate risk management strategy. These interest rate products are designated as cash flow hedges. As of March 31, 2022, the Company had a total of 10 interest rate swaps and caps with a total notional amount of $ 790.0 million hedging specific wholesale funding positions.

For derivatives designated as cash flow hedges, the gain or loss on the derivative is recorded in other comprehensive income, net of tax, and subsequently reclassified into interest expense in the same period during which the hedged transaction affects earnings.

Amounts reported in accumulated other comprehensive income related to derivatives will be reclassified to interest expense as interest payments are made on the Company’s variable rate wholesale funding positions. During the three months and nine months ended March 31, 2022 the Company reclassified $ 1.3 million and $ 4.3 million , respectively, as additional interest expense. During the next twelve months, the Company estimates that $ 4.6 million will be reclassified as a reduction in interest expense.

The table below presents the pre-tax effects of the Company’s derivative instruments on the Consolidated Statements of Income for the three months and nine months ended March 31, 2022 and 2021:

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

(In Thousands)

(In Thousands)

Amount of gain recognized in other comprehensive income

$

23,343

$

13,075

$

28,607

$

14,353

Amount of loss reclassified from accumulated other comprehensive income
to interest expense

( 1,268

)

( 1,987

)

( 4,271

)

( 6,576

)

- 27 -


Offsetting Derivatives

The tables below present a gross presentation, the effects of offsetting, and a net presentation of the Company’s derivatives in the Consolidated Statements of Financial Condition as of March 31, 2022 and June 30, 2021, respectively. The net amounts presented for derivative assets or liabilities can be reconciled to the tabular disclosure of fair value. The tabular disclosure of fair value provides the location that derivative assets and liabilities are presented on the Consolidated Statements of Financial Condition.

March 31, 2022

Gross Amounts Not Offset

Gross Amount Recognized

Gross Amounts Offset

Net Amounts Presented

Financial Instruments

Cash Collateral Received

Net Amount

(In Thousands)

Assets:

Interest rate contracts

$

34,158

$

( 151

)

$

34,007

$

-

$

-

$

34,007

Total

$

34,158

$

( 151

)

$

34,007

$

-

$

-

$

34,007

Gross Amounts Not Offset

Gross Amount Recognized

Gross Amounts Offset

Net Amounts Presented

Financial Instruments

Cash Collateral Posted

Net Amount

(In Thousands)

Liabilities:

Interest rate contracts

$

151

$

( 151

)

$

-

$

-

$

-

$

-

Total

$

151

$

( 151

)

$

-

$

-

$

-

$

-

June 30, 2021

Gross Amounts Not Offset

Gross Amount Recognized

Gross Amounts Offset

Net Amounts Presented

Financial Instruments

Cash Collateral Received

Net Amount

(In Thousands)

Assets:

Interest rate contracts

$

6,847

$

( 5,015

)

$

1,832

$

-

$

-

$

1,832

Total

$

6,847

$

( 5,015

)

$

1,832

$

-

$

-

$

1,832

Gross Amounts Not Offset

Gross Amount Recognized

Gross Amounts Offset

Net Amounts Presented

Financial Instruments

Cash Collateral Posted

Net Amount

(In Thousands)

Liabilities:

Interest rate contracts

$

5,688

$

( 5,015

)

$

673

$

-

$

( 673

)

$

-

Total

$

5,688

$

( 5,015

)

$

673

$

-

$

( 673

)

$

-

Credit Risk-Related Contingent Features

The Company has agreements with each of its derivative counterparties that contain a provision where if the Company defaults on any of its indebtedness, then the Company could also be declared in default on its derivative obligations and could be required to terminate its derivative positions with the counterparty. The Company also has agreements with its derivative counterparties that contain a provision where if the Company fails to maintain its status as a well-capitalized institution, then the Company could be required to terminate its derivative positions with the counterparty. At March 31, 2022 , no ne of the Company’s derivatives were in a net liability position. As required under the enforceable master netting arrangement with its derivatives counterparties, at March 31, 2022, the Company was not required to post financial collateral.

In addition to the derivative instruments noted above, the Company’s pipeline of loans held for sale at March 31, 2022 and June 30, 2021, included $ 16.0 million and $ 48.4 million , respectively, of in process loans whose terms included interest rate locks to borrowers, which are considered free-standing derivative instruments whose fair values are not material to the Company’s financial condition or results of operations.

- 28 -


10. BENEFIT PLANS

Components of Net Periodic Expense

The following table sets forth the aggregate net periodic benefit expense for the Bank’s Benefit Equalization Plan, Postretirement Welfare Plan, Directors’ Consultation and Retirement Plan and Atlas Bank Retirement Income Plan:

Three Months Ended

Nine Months Ended

Affected Line Item in the Consolidated

March 31,

March 31,

Statements of Income

2022

2021

2022

2021

(In Thousands)

(In Thousands)

Service cost

$

29

$

26

$

87

$

79

Salaries and employee benefits

Interest cost

67

66

205

197

Other expense

Amortization of unrecognized loss

20

20

60

62

Other expense

Expected return on assets

( 27

)

( 28

)

( 83

)

( 85

)

Other expense

Net periodic benefit cost

$

89

$

84

$

269

$

253

2021 Equity Incentive Plan

At the Company’s 2021 Annual Meeting of Stockholders held on October 28, 2021, the stockholders approved the Kearny Financial Corp. 2021 Equity Incentive Plan (“2021 Plan”) which provides for the grant of stock options, restricted stock and restricted stock units ( “RSUs”) . The 2021 Plan authorized the issuance of up to 7,500,000 shares (the “Share Limit”); provided, however that the Share Limit is reduced, on a one-for-one-basis, for each share of common stock subject to a stock option grant, and on a three-for-one basis for each share of common stock issued pursuant to restricted stock awards or RSUs.

During the quarter ended March 31, 2022, the Company granted 251,905 RSUs comprised of 181,588 service-based RSUs and 70,317 performance-based RSUs. The service-based RSUs will vest in three tranches over a period of 2.6 years and the performance-based RSUs will cliff vest upon the achievement of performance measures over the three-year period ending June 30, 2024. The total number of performance-based RSUs that will vest, if any, will depend on whether and to what extent the performance measures are achieved. Common stock will be issued from authorized shares upon the vesting of the RSUs.

11. INCOME TAXES

The following table presents a reconciliation between the reported income taxes for the periods presented and the income taxes which would be computed by applying the federal income tax rate of 21 % to income for the three months and nine months ended March 31, 2022 and 2021:

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

(Dollars in Thousands)

(Dollars in Thousands)

Income before income taxes

$

24,215

$

22,155

$

76,772

$

58,980

Statutory federal tax rate

21

%

21

%

21

%

21

%

Federal income tax expense at statutory rate

$

5,085

$

4,653

$

16,122

$

12,386

(Reduction) increase in income taxes resulting from:

Tax exempt interest

( 66

)

( 85

)

( 204

)

( 270

)

State tax, net of federal tax effect

1,908

1,498

6,026

3,738

Incentive stock option compensation expense

3

23

42

63

Income from bank-owned life insurance

( 317

)

( 324

)

( 973

)

( 989

)

Non-deductible merger-related expenses

-

-

-

49

Bargain purchase gain

-

-

-

( 641

)

Other items, net

( 91

)

( 21

)

( 418

)

429

$

6,522

$

5,744

$

20,595

$

14,765

Reversal of valuation allowance

-

( 12

)

-

( 535

)

Total income tax expense

$

6,522

$

5,732

$

20,595

$

14,230

Effective income tax rate

26.93

%

25.87

%

26.83

%

24.13

%

- 29 -


12. FAIR VALUE OF FINANCIAL INSTRUMENTS

Fair value is the exchange price that would be received for an asset or paid to transfer a liability (exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. There are three levels of inputs that may be used to measure fair values:

Level 1:

Quoted prices (unadjusted) for identical assets or liabilities in active markets that the entity has the ability to access as of the measurement date.

Level 2:

Inputs other than quoted prices included in Level 1 that are observable for the asset or liability, either directly or indirectly. These might include quoted prices for similar assets or liabilities in active markets, quoted prices for identical or similar assets or liabilities in markets that are not active, inputs other than quoted prices that are observable for the asset or liability or inputs that are derived principally from, or corroborated by, market data by correlation or other means.

Level 3:

Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.

Assets Measured on a Recurring Basis:

The following methods and significant assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a recurring basis at March 31, 2022 and June 30, 2021:

Investment Securities Available for Sale

The Company’s available for sale investment securities are reported at fair value utilizing Level 2 inputs. For these securities, the Company obtains fair value measurements from an independent pricing service. The fair value measurements consider observable data that may include dealer quotes, market spreads, cash flows, the U.S. Treasury yield curve, live trading levels, trade execution data, market consensus prepayment speeds, credit information and the securities’ terms and conditions, among other things. From time to time, the Company validates prices supplied by the independent pricing service by comparison to prices obtained from third-party sources or derived using internal models.

Derivatives

The Company has contracted with a third party vendor to provide periodic valuations for its interest rate derivatives to determine the fair value of its interest rate caps and swaps. The vendor utilizes standard valuation methodologies applicable to interest rate derivatives such as discounted cash flow analysis and extensions of the Black-Scholes model. Such valuations are based upon readily observable market data and are therefore considered Level 2 valuations by the Company.

- 30 -


Those assets measured at fair value on a recurring basis are summarized below:

March 31, 2022

Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Total

(In Thousands)

Assets:

Debt securities available for sale:

Obligations of state and political subdivisions

$

-

$

31,078

$

-

$

31,078

Asset-backed securities

-

229,584

-

229,584

Collateralized loan obligations

-

311,620

-

311,620

Corporate bonds

-

153,495

-

153,495

Total debt securities

-

725,777

-

725,777

Mortgage-backed securities available for sale:

Collateralized mortgage obligations

-

7,996

-

7,996

Residential pass-through securities

-

570,150

-

570,150

Commercial pass-through securities

-

222,163

-

222,163

Total mortgage-backed securities

-

800,309

-

800,309

Total securities available for sale

$

-

$

1,526,086

$

-

$

1,526,086

Interest rate contracts

$

-

$

34,007

$

-

$

34,007

Total assets

$

-

$

1,560,093

$

-

$

1,560,093

- 31 -


June 30, 2021

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Total

(In Thousands)

Assets:

Debt securities available for sale:

Obligations of state and political subdivisions

$

-

$

34,603

$

-

$

34,603

Asset-backed securities

-

242,989

-

242,989

Collateralized loan obligations

-

189,880

-

189,880

Corporate bonds

-

158,351

-

158,351

Total debt securities

-

625,823

-

625,823

Mortgage-backed securities available for sale:

Collateralized mortgage obligations

-

13,739

-

13,739

Residential pass-through securities

-

744,491

-

744,491

Commercial pass-through securities

-

292,811

-

292,811

Total mortgage-backed securities

-

1,051,041

-

1,051,041

Total securities available for sale

$

-

$

1,676,864

$

-

$

1,676,864

Interest rate contracts

$

-

$

1,832

$

-

$

1,832

Total assets

$

-

$

1,678,696

$

-

$

1,678,696

Liabilities:

Interest rate contracts

$

-

$

673

$

-

$

673

Total liabilities

$

-

$

673

$

-

$

673

Assets Measured on a Non-Recurring Basis:

The following methods and assumptions were used to estimate the fair values of the Company’s assets measured at fair value on a non-recurring basis at March 31, 2022 and June 30, 2021:

Collateral Dependent Individually Analyzed Loans

The fair value of collateral dependent loans that are individually analyzed is determined based upon the appraised fair value of the underlying collateral, less costs to sell. Such collateral primarily consists of real estate and, to a lesser extent, other business assets. Management may also adjust appraised values to reflect estimated changes in market values or apply other adjustments to appraised values resulting from its knowledge of the collateral. Internal valuations may be utilized to determine the fair value of other business assets. For non-collateral-dependent loans, management estimates fair value using discounted cash flows based on inputs that are largely unobservable and instead reflect management’s own estimates of the assumptions as a market participant would in pricing such loans. Collateral dependent individually analyzed loans are considered a Level 3 valuation by the Company.

- 32 -


Other Real Estate Owned

Other real estate owned is recorded at estimated fair value, less estimated selling costs when acquired, thus establishing a new cost basis. Fair value is generally based on independent appraisals. These appraisals include adjustments to comparable assets based on the appraisers’ market knowledge and experience. When an asset is acquired, the excess of the loan balance over fair value, less estimated selling costs, is charged to the allowance for credit losses. If further declines in the estimated fair value of the asset occur, a write-down is recorded through expense. The valuation of foreclosed assets is subjective in nature and may be adjusted in the future because of changes in economic conditions.

Those assets measured at fair value on a non-recurring basis are summarized below:

March 31, 2022

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Total

(In Thousands)

Collateral dependent loans:

Residential mortgage

$

-

$

-

$

2,239

$

2,239

Multi-family mortgage

-

-

4,558

4,558

Nonresidential mortgage

-

-

5,799

5,799

Total

$

-

$

-

$

12,596

$

12,596

Other real estate owned, net:

Residential

$

-

$

-

$

401

$

401

Total

$

-

$

-

$

401

$

401

June 30, 2021

Quoted Prices
in Active
Markets for
Identical
Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

Total

(In Thousands)

Collateral dependent loans:

Residential mortgage

$

-

$

-

$

3,051

$

3,051

Multi-family mortgage

6,932

6,932

Nonresidential mortgage

-

-

8,679

8,679

Total

$

-

$

-

$

18,662

$

18,662

Other real estate owned, net:

Residential

$

-

$

-

$

178

$

178

Total

$

-

$

-

$

178

$

178

- 33 -


The following table presents additional quantitative information about assets measured at fair value on a non-recurring basis and for which the Company has utilized adjusted Level 3 inputs to determine fair value:

March 31, 2022

Fair
Value

Valuation
Techniques

Unobservable
Input

Range

Weighted
Average

(Dollars in Thousands)

Collateral dependent loans:

Residential mortgage

$

2,239

Market valuation of underlying collateral

(1)

Adjustments to reflect current conditions/selling costs

(2)

7 % - 14 %

10.39

%

Multi-family mortgage

4,558

Market valuation of underlying collateral

(1)

Adjustments to reflect current conditions/selling costs

(2)

10 % - 11 %

10.60

%

Nonresidential mortgage

5,799

Market valuation of underlying collateral

(1)

Adjustments to reflect current conditions/selling costs

(2)

9 % - 19 %

14.97

%

Total

$

12,596

Other real estate owned, net:

Residential

$

401

Market valuation of underlying collatera l

(3)

Adjustments to reflect current conditions/selling costs

(2)

5 % - 6 %

5.44

%

Total

$

401

June 30, 2021

Fair
Value

Valuation
Techniques

Unobservable
Input

Range

Weighted
Average

(Dollars in Thousands)

Collateral dependent loans:

Residential mortgage

$

3,051

Market valuation of underlying collateral

(1)

Adjustments to reflect current conditions/selling costs

(2)

7 % - 13 %

9.77

%

Multi-family mortgage

6,932

Market valuation of underlying collateral

(1)

Adjustments to reflect current conditions/selling costs

(2)

10 % - 11 %

10.39

%

Nonresidential mortgage

8,679

Market valuation of underlying collateral

(1)

Adjustments to reflect current conditions/selling costs

(2)

9 % - 16 %

14.48

%

Total

$

18,662

Other real estate owned, net:

Residential

$

178

Market valuation of underlying collateral

(3)

Adjustments to reflect current conditions/selling costs

(2)

6.00 %

6.00

%

Total

$

178

(1)
The fair value of collateral dependent individually analyzed loans is generally determined based on an independent appraisal of the fair value of a loan’s underlying collateral.
(2)
The fair value basis of collateral dependent individually analyzed loans and other real estate owned is adjusted to reflect management’s estimates of selling costs including, but not necessarily limited to, real estate brokerage commissions and title transfer fees.
(3)
The fair value of other real estate owned is generally determined based upon the lower of an independent appraisal of the property’s fair value or the applicable listing price or contracted sales price.

- 34 -


At March 31, 2022 , collateral dependent loans valued using Level 3 inputs comprised loans with principal balance totaling $ 13.6 million and valuation allowances of $ 976,000 reflecting fair values of $ 12.6 million. By comparison, at June 30, 2021 , collateral dependent loans valued using Level 3 inputs comprised loans with principal balance totaling $ 25.2 million and valuation allowances of $ 6.5 million reflecting fair values of $ 18.7 million.

Once a loan is foreclosed, the fair value of the other real estate owned continues to be evaluated based upon the fair value of the repossessed real estate originally securing the loan. At March 31, 2022 and June 30, 2021, the Company held other real estate owned totaling $ 401,000 an d $ 178,000 , respectively, whose carrying value was written down utilizing Level 3 inputs.

The following tables present the carrying amount, fair value, and placement in the fair value hierarchy of the Company’s financial instruments as of March 31, 2022 and June 30, 2021:

March 31, 2022

Carrying
Amount

Fair
Value

Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

(In Thousands)

Financial assets:

Cash and cash equivalents

$

62,379

$

62,379

$

62,379

$

-

$

-

Investment securities available for sale

1,526,086

1,526,086

-

1,526,086

-

Investment securities held to maturity

121,853

117,017

-

117,017

-

Loans held-for-sale

2,822

2,759

-

2,759

-

Net loans receivable

4,959,341

4,877,212

-

-

4,877,212

FHLB Stock

30,997

-

-

-

-

Interest receivable

19,517

19,517

3

5,311

14,203

Interest rate contracts

34,007

34,007

-

34,007

-

Financial liabilities:

Deposits

5,528,662

5,515,560

3,865,416

-

1,650,144

Borrowings

851,220

853,824

-

-

853,824

Interest payable on deposits

164

164

79

-

85

Interest payable on borrowings

1,365

1,365

-

-

1,365

- 35 -


June 30, 2021

Carrying
Amount

Fair
Value

Quoted
Prices
in Active
Markets for
Identical
Assets
(Level 1)

Significant
Other
Observable
Inputs
(Level 2)

Significant
Unobservable
Inputs
(Level 3)

(In Thousands)

Financial assets:

Cash and cash equivalents

$

67,855

$

67,855

$

67,855

$

-

$

-

Investment securities available for sale

1,676,864

1,676,864

-

1,676,864

-

Investment securities held to maturity

38,138

39,610

-

39,610

-

Loans held-for-sale

16,492

16,934

-

16,934

-

Net loans receivable

4,793,229

4,830,136

-

-

4,830,136

FHLB Stock

36,615

-

-

-

-

Interest receivable

19,362

19,362

1

4,238

15,123

Interest rate contracts

1,832

1,832

-

1,832

-

Financial liabilities:

Deposits

5,485,306

5,490,923

3,607,560

-

1,883,363

Borrowings

685,876

701,419

-

-

701,419

Interest payable on deposits

145

145

96

-

49

Interest payable on borrowings

1,335

1,335

-

-

1,335

Interest rate contracts

673

673

-

673

-

Commitments. The fair value of commitments to fund credit lines and originate or participate in loans held in portfolio or loans held for sale is estimated using fees currently charged to enter into similar agreements taking into account the remaining terms of the agreements and the present creditworthiness of the counterparties. For fixed rate loan commitments, including those relating to loans held for sale that are considered derivative instruments for financial statement reporting purposes, the fair value also considers the difference between current levels of interest and the committed rates. The carrying value, represented by the net deferred fee arising from the unrecognized commitment, and the fair value, determined by discounting the remaining contractual fee over the term of the commitment using fees currently charged to enter into similar agreements with similar credit risk, is not considered material for disclosure.

Limitations. Fair value estimates are made at a specific point in time based on relevant market information and information about the financial instruments. These estimates do not reflect any premium or discount that could result from offering for sale at one time the entire holdings of a particular financial instrument. Because no fair value exists for a significant portion of the financial instruments, fair value estimates are based on judgments regarding future expected loss experience, current economic conditions, risk characteristics of various financial instruments and other factors. These estimates are subjective in nature, involve uncertainties and matters of judgment and, therefore, cannot be determined with precision. Changes in assumptions could significantly affect the estimates.

The fair value estimates are based on existing on-and-off balance sheet financial instruments without attempting to value anticipated future business and the value of assets and liabilities that are not considered financial instruments. Other significant assets and liabilities that are not considered financial assets and liabilities include premises and equipment, and advances from borrowers for taxes and insurance. In addition, the ramifications related to the realization of the unrealized gains and losses can have a significant effect on fair value estimates and have not been considered in any of the estimates.

Finally, reasonable comparability between financial institutions may not be likely due to the wide range of permitted valuation techniques and numerous estimates which must be made given the absence of active secondary markets for many of the financial instruments. This lack of uniform valuation methodologies introduces a greater degree of subjectivity to these estimated fair values.

- 36 -


13. COMPREHENSIVE INCOME (LOSS)

The components of accumulated other comprehensive (loss) income included in stockholders’ equity at March 31, 2022 and June 30, 2021 are as follows:

March 31,

June 30,

2022

2021

(In Thousands)

Net unrealized (loss) gain on securities available for sale

$

( 63,988

)

$

10,011

Tax effect

18,760

( 2,882

)

Net of tax amount

( 45,228

)

7,129

Fair value adjustments on derivatives

32,566

( 312

)

Tax effect

( 9,557

)

94

Net of tax amount

23,009

( 218

)

Benefit plan adjustments

( 1,033

)

( 1,093

)

Tax effect

303

326

Net of tax amount

( 730

)

( 767

)

Total accumulated other comprehensive (loss) income

$

( 22,949

)

$

6,144

Other comprehensive (loss) income and related tax effects for the three months and nine months ended March 31, 2022 and 2021 are presented in the following table:

Three Months Ended

Nine Months Ended

March 31,

March 31,

2022

2021

2022

2021

(In Thousands)

Net unrealized holding loss on securities
available for sale

$

( 59,249

)

$

( 22,285

)

$

( 73,995

)

$

( 20,374

)

Net realized gain on sale and call of securities
available for sale
(1)

( 3

)

( 18

)

( 4

)

( 454

)

Fair value adjustments on derivatives

24,611

15,062

32,878

20,929

Amortization of benefit plan net actuarial loss

20

20

60

62

Other comprehensive (loss) income before taxes

( 34,621

)

( 7,221

)

( 41,061

)

163

Tax effect

10,098

2,125

11,968

( 63

)

Total other comprehensive (loss) income

$

( 24,523

)

$

( 5,096

)

$

( 29,093

)

$

100

(1)
Represents amounts reclassified out of accumulated other comprehensive income and included in gain on sale of securities on the consolidated statements of income.

- 37 -


14. NET INCOME PER COMMON SHARE (“EPS”)

The following schedule shows the Company’s earnings per share calculations for the periods presented:

Three Months Ended March 31,

Nine Months Ended March 31,

2022

2021

2022

2021

(In Thousands, Except Per Share Data)

Net income

$

17,693

$

16,423

$

56,177

$

44,750

Weighted average number of common shares
outstanding - basic

69,790

80,673

72,130

83,958

Effect of dilutive securities

27

17

24

3

Weighted average number of common shares
outstanding - diluted

69,817

80,690

72,154

83,961

Basic earnings per share

$

0.25

$

0.20

$

0.78

$

0.53

Diluted earnings per share

$

0.25

$

0.20

$

0.78

$

0.53

Stock option s for 3,115,000 and 3,253,040 shares of common stock were not considered in computing diluted earnings per share at March 31, 2022 and March 31, 2021, respectively, because the stock options were considered anti-dilutive. In addition, 251,905 RSUs were not considered in computing diluted earnings per share at March 31, 2022 because the RSUs were considered anti-dilutive.

- 38 -


ITEM 2.

MANAGEMENT’S DISCUSSION AND ANALYSIS OF

FINANCIAL CONDITION AND RESULTS OF OPERATIONS

Forward-Looking Statements

This Quarterly Report on Form 10-Q may include certain forward-looking statements based on current management expectations. Such forward-looking statements may be identified by reference to a future period or periods or by the use of forward-looking terminology, such as “may”, “will”, “believe”, “expect”, “estimate”, “anticipate”, “continue”, or similar terms or variations on those terms, or the negative of those terms. The actual results of the Company could differ materially from those management expectations. This includes statements regarding general economic conditions, public health crisis such as the governmental, social and economic effects of the novel coronavirus, legislative and regulatory changes, monetary and fiscal policies of the federal government, changes in tax policies, rates and regulations of federal, state and local tax authorities and failure to integrate or profitably operate acquired businesses. Additional potential factors include changes in interest rates, the rate of inflation, deposit flows, cost of funds, demand for loan products and financial services, competition and changes in the quality or composition of loan and investment portfolios of the Company. Other factors that could cause future results to vary from current management expectations include changes in accounting principles, policies or guidelines, and other economic, competitive, governmental and technological factors affecting the Company’s operations, markets, products, services and prices. Further description of the risks and uncertainties to the business are included in the Company’s other filings with the Securities and Exchange Commission.

In addition, the COVID-19 pandemic has had, and may continue to have, an adverse impact on the Company, its clients and the communities it serves. Given its ongoing and dynamic nature, it is difficult to predict the full impact of the COVID-19 pandemic on our business. The extent of such impact will depend on future developments, which are highly uncertain, including whether the coronavirus can continue to be controlled and abated. As the result of the COVID-19 pandemic and the related adverse local and national economic consequences, we could be subject to any of the following risks, any of which could have a material, adverse effect on our business, financial condition, liquidity, and results of operations: the demand for our products and services may decline, making it difficult to grow assets and income; if the economy worsens, loan delinquencies, problem assets, and foreclosures may increase, resulting in increased charges and reduced income; collateral for loans, especially real estate, may decline in value, which could cause loan losses to increase; our allowance for credit losses may increase if borrowers experience financial difficulties, which will adversely affect our net income; the net worth and liquidity of loan guarantors may decline, impairing their ability to honor commitments to us; due to a decline in our stock price or other factors, goodwill may become impaired and be required to be written down; and our cyber security risks are increased as the result of an increase in the number of employees working remotely. Reference is made to Item 1A “Risk Factors” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021.

Except as required by applicable law or regulation, the Company does not undertake, and specifically disclaims any obligation, to release publicly the result of any revisions that may be made to any forward-looking statements to reflect events or circumstances after the date of the statements or to reflect the occurrence of anticipated or unanticipated events.

Critical Accounting Policies

Our accounting policies are integral to understanding the results reported. We consider accounting policies that require management to exercise significant judgment or discretion or to make significant assumptions that have, or could have, a material impact on the carrying value of certain assets or on income to be critical accounting policies. At March 31, 2022, we consider the determination of the allowance for credit losses on loans, individually evaluating loans, calculating the allowance of credit losses on acquired loans, accounting for business combinations and the valuation of goodwill and identifiable intangible assets to be our critical accounting policies. Reference is made to Item 7 “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in the Company’s Annual Report on Form 10-K for the year ended June 30, 2021, for a description of the Company’s critical accounting policies.

- 39 -


Comparison of Financial Condition at March 31, 2022 and June 30, 2021

Executive Summary. Total assets increased $106.2 million to $7.39 billion at March 31, 2022 from $7.28 billion at June 30, 2021 . The increase primarily reflected an increase in net loans receivable, partially offset by a decrease in investment securities.

Investment Securities. Investment securities available for sale decreased $150.8 million to $1.53 billion at March 31, 2022, from $1.68 billion at June 30, 2021. This decrease was largely the result of principal repayments of $280.5 million and a fair value decrease of $74.0 million, partially offset by security purchases of $206.1 million. Investment securities held to maturity increased $83.7 million to $121.9 million at March 31, 2022 from $38.1 million at June 30, 2021. This increase was largely the result of security purchases of $86.4 million, partially offset by principal repayments of $2.6 million.

Additional information regarding our investment securities at March 31, 2022 and June 30, 2021 is presented in Note 4 to the unaudited consolidated financial statements.

Loans Held-for-Sale. Loans held-for-sale totaled $2.8 million at March 31, 2022 as compared to $16.5 million at June 30, 2021 and are reported separately from the balance of net loans receivable . During the nine months ended March 31, 2022, $165.5 million of residential mortgage loans were sold, resulting in a gain on sale of $2.3 million.

Net Loans Receivable. Net loans receivable increased $166.1 million, or 3.5%, to $4.96 billion at March 31, 2022 from $4.79 billion at June 30, 2021. Detail regarding the change in the loan portfolio, by loan segment, is presented below:

March 31,

June 30,

Increase/

2022

2021

(Decrease)

(In Thousands)

Commercial loans:

Multi-family mortgage

$

2,076,003

$

2,039,260

$

36,743

Nonresidential mortgage

1,085,988

1,079,444

6,544

Commercial business

169,551

168,951

600

Construction

121,137

93,804

27,333

Total commercial loans

3,452,679

3,381,459

71,220

One- to four-family residential mortgage

1,527,980

1,447,721

80,259

Consumer loans:

Home equity loans

41,501

47,871

(6,370

)

Other consumer

2,755

3,259

(504

)

Total consumer loans

44,256

51,130

(6,874

)

Total loans

5,024,915

4,880,310

144,605

Unaccreted yield adjustments

(21,714

)

(28,916

)

7,202

Allowance for credit losses

(43,860

)

(58,165

)

14,305

Net loans receivable

$

4,959,341

$

4,793,229

$

166,112

Commercial loan origination volume for the nine months ended March 31, 2022 totaled $834.0 million, comprised of $667.1 million of commercial mortgage loan originations, $105.5 million of commercial business loan originations and construction loan disbursements of $61.4 million. Co mmercial loan origination volume was augmented with the funding of purchased commercial mortgage loans totali ng $55.8 million.

One- to four-family residential mortgage loan origination volume for the nine months ended March 31, 2022, excluding loans held-for-sale, totale d $262.7 million an d was augmented with the funding of purchased loans tota ling $56.5 million. Home equity loan and line of credit origination volume for the same period tota led $13.5 million.

- 40 -


Loan-to-value ( “LTV”) ratios are based on current period loan balances and original appraised values at the time of origination unless a current appraisal has been obtained as a result of the loan being deemed collateral dependent and individually analyzed . The following table sets forth the composition of our real estate secured loans indicating the LTV, by loan category, at March 31, 2022 and June 30, 2021:

March 31, 2022

June 30, 2021

Balance

LTV

Balance

LTV

(Dollars in Thousands)

Commercial mortgage loans:

Multi-family mortgage

$

2,076,003

64

%

$

2,039,260

64

%

Nonresidential mortgage

1,085,988

54

%

1,079,444

54

%

Construction

121,137

59

%

93,804

61

%

Total commercial mortgage loans

3,283,128

61

%

3,212,508

61

%

One- to four-family residential mortgage

1,527,980

61

%

1,447,721

59

%

Consumer loans:

Home equity loans

41,501

46

%

47,871

47

%

Total mortgage loans

$

4,852,609

61

%

$

4,708,100

60

%

Additional information about our loans at March 31, 2022 and June 30, 2021 is presented in Note 5 to the unaudited consolidated financial statements.

Nonperforming Assets and TDRs. Nonperforming assets increased by $1.1 million to $81.0 million, or 1.10% of total assets at March 31, 2022, from $79.9 million, or 1.10% of total assets at June 30, 2021. At March 31, 2022, we had accruing TDRs totaling $8.5 million, an increase of $2.3 million from $6.2 million at June 30, 2021. At March 31, 2022, we had non-accrual TDRs totaling $23.2 million, an increase of $11.6 million from $11.6 million at June 30, 2021.

Based on Section 4013 of the CARES Act, the 2021 Consolidated Appropriations Act and related regulatory guidance promulgated by federal banking regulators, qualifying loan modifications made in response to the COVID-19 pandemic, including short-term payment deferrals, were not considered to be TDRs. We had no active payment deferrals that were not considered TDRs as of March 31, 2022. We had active payment deferrals, which were not considered TDRs, of $5.6 million as of June 30, 2021.

Additional information about our nonperforming loans and TDRs at March 31, 2022 and June 30, 2021 is presented in Note 5 to the unaudited consolidated financial statements.

Allowance for Credit Losses ( ACL ). At March 31, 2022, the ACL totaled $43.9 million, or 0.87% of total loans, reflecting a decrease of $14.3 million from $58.2 million, or 1.19% of total loans, at June 30, 2021. The decrease d uring the nine months ended March 31, 2022 was largely attributable to a provision for credit loss es reversal o f $11.7 million, primarily driven by continued improvement in our economic forecast, a reduction in the expected life of various segments of the loan portfolio and a net reduction in reserves on loans individually evaluated for impairment. Also contributing to this decrease were net charge-offs of $2.6 million, which had been individually reserved for within the ACL at June 30, 2021.

Additional information about our ACL at March 31, 2022 and June 30, 2021 is presented in Note 6 to the unaudited consolidated financial statements.

Other Assets. The aggregate balance of other assets, including premises and equipment, FHLB stock, interest receivable, goodwill, core deposit intangibles, bank owned life insurance, deferred income taxes, OREO and other assets, increased $26.3 million to $717.4 million at March 31, 2022 from $691.2 million at June 30, 2021. Th e increase in t he balance of these other assets during the nine months ended March 31, 2022 largely reflected a $32.2 million increa se in the fair value of our derivatives portfolio. The remaining change generally reflected normal operating fluctuations within these line items.

- 41 -


Deposits. Total deposits increased $43.4 million, or 0.8%, to $5.53 billion at March 31, 2022 from $5.49 billion at June 30, 2021. The increase in depo sits largely reflected growth in core non-maturity deposits, which was partially offset by the controlled run-off of time deposits. The following table sets forth the distribution of, and changes in, deposits, by type, for the periods indicated:

March 31,

June 30,

Increase/

2022

2021

(Decrease)

(In Thousands)

Non-interest-bearing deposits

$

621,954

$

593,718

$

28,236

Interest-bearing deposits:

Interest-bearing demand

2,154,488

1,902,478

252,010

Savings

1,088,974

1,111,364

(22,390

)

Certificates of deposit

1,663,246

1,877,746

(214,500

)

Interest-bearing deposits

4,906,708

4,891,588

15,120

Total deposits

$

5,528,662

$

5,485,306

$

43,356

Additional information about our deposits at March 31, 2022 and June 30, 2021 is presented in Note 7 to the unaudited consolidated financial statements.

Borrowings. The balance of borrowings increased by $165.3 million to $851.2 million at March 31, 2022 from $685.9 million at June 30, 2021.

Additional information about our borrowings at March 31, 2022 and June 30, 2021 is presented in Note 8 to the unaudited consolidated financial statements.

Other Liabilities. The balance of other liabilities, including advance payments by borrowers for taxes and other miscellaneous liabilities, decreased $14.8 million to $54.8 million at March 31, 2022 from $69.6 million at June 30, 2021. The decrease in these other liabilities largely reflecte d the payment of a $12.5 million loan participation liability which was outstanding at June 30, 2021. The remaining change in the balance of these other liabilities generally reflected normal operating fluctuations during the period.

Stockholders’ Equity. Stockholders’ equity decreased $87.8 million to $955.2 million at March 31, 2022 from $1.04 billion at June 30, 2021. The decrease in stockholders’ equity during the nine months ended March 31, 2022 largely reflected share repurchases totaling $96.0 million and cash dividends totaling $23.0 million. In addition, accumulated other comprehensive (loss) income decreased $29.1 million due primarily to a decline in the fair value of our available for sale securities, partially offset by an increase in the fair value of our derivatives portfolio. These decreases were partially offset by net income of $56.2 million.

Book value per share increased by $0.16 to $13.37 at March 31, 2022 while tangible book value per share decreased by $0.11 to $10.38 at March 31, 2022.

On September 22, 2021, we announced the authorization of a new stock repurchase plan, which authorized the repurchase of up to 7,602,021 shares, or 10% of the shares then outstanding. During the quarter ended March 31, 2022, we repurchased 2,019,625 shares of common stock at a cost of $27.0 million, or $13.35 per share. Through March 31, 2022, we repurchased a total of 4,522,301 shares, or 59.5% of the shares authorized for repurchase under the current repurchase program, at a total cost of $59.6 million or $13.18 per share.

- 42 -


Comparison of Operating Results for the Quarter Ended March 31, 2022 and March 31, 2021

Net Income . Net income for the quarter ended March 31, 2022 was $17.7 million, or $0.25 per diluted share, compared to $16.4 million, or $0.20 per diluted share for the quarter ended March 31, 2021. The increase in net income reflected a decrease in the provision for credit losses, partially offset by a decrease in net interest income, a decrease in non-interest income, an increase in non-interest expense and an increase in income tax expense.

Net Interest Income . Effective July 1, 2021, loan prepayment penalty income was reclassified to interest income on loans. Previously, loan prepayment penalty income was recorded within non-interest income. Interest income and non-interest income for all periods presented reflect this reclassification.

Net interest incom e decreased b y $756,000 to $47.7 million for the quarter ended March 31, 2022 compared to $48.5 million for the quarter ended March 31, 2021. Th e decrease be tween the comparative periods resulted from a decrease o f $4.6 million in interest income, partially offset by a decrease of $3.8 million in interest expense. Included in net interest income for the quarters ended March 31, 2022 and March 31, 2021, respectively, was purchase accounting accretion of $1.9 million and $4.8 million and loan prepayment penalty income of $1.3 million and $852,000.

Net interest mar gin increased one basis point to 2.89% fo r the quarter ended March 31, 2022, from 2.88% for the quarter ended March 31, 2021 and reflected a decrease in the average cost of interest-bearing liabilities that was partially offset by a decrease in the average yield on interest-earning assets.

Details surrounding the composition of, and changes to, net interest income are presented in the table below which reflects the components of the average balance sheet and of net interest income for the periods indicated. We derived the average yields and costs by dividing income or expense by the average balance of assets or liabilities, respectively, for the periods presented with daily balances used to derive average balances. No tax equivalent adjustments have been made to yield or costs. Non-accrual loans were included in the calculation of average balances, however interest receivable on these loans has been fully reserved for and therefore not included in interest income. The yields and costs set forth below include the effect of deferred fees, discounts and premiums that are amortized or accreted to interest income or expense.

- 43 -


For the Three Months Ended March 31,

2022

2021

Average
Balance

Interest

Average
Yield/
Cost

Average
Balance

Interest

Average
Yield/
Cost

(Dollars in Thousands)

Interest-earning assets:

Loans receivable (1)

$

4,850,236

$

45,846

3.78

%

$

4,816,592

$

50,159

4.17

%

Taxable investment securities (2)

1,620,996

8,024

1.98

1,674,223

7,891

1.89

Tax-exempt securities (2)

55,390

316

2.28

73,573

410

2.23

Other interest-earning assets (3)

79,644

415

2.08

169,291

705

1.67

Total interest-earning assets

6,606,266

54,601

3.31

6,733,679

59,165

3.51

Non-interest-earning assets

601,684

617,440

Total assets

$

7,207,950

$

7,351,119

Interest-bearing liabilities:

Interest-bearing demand

$

2,133,977

$

1,166

0.22

$

1,831,617

$

1,558

0.34

Savings

1,088,351

274

0.10

1,084,981

557

0.21

Certificates of deposit

1,650,048

2,125

0.52

1,904,234

4,555

0.96

Total interest-bearing deposits

4,872,376

3,565

0.29

4,820,832

6,670

0.55

Borrowings

684,478

3,309

1.93

865,690

4,012

1.85

Total interest-bearing liabilities

5,556,854

6,874

0.49

5,686,522

10,682

0.75

Non-interest-bearing liabilities (4)

673,607

582,036

Total liabilities

6,230,461

6,268,558

Stockholders' equity

977,489

1,082,561

Total liabilities and stockholders' equity

$

7,207,950

$

7,351,119

Net interest income

$

47,727

$

48,483

Interest rate spread (5)

2.82

%

2.76

%

Net interest margin (6)

2.89

%

2.88

%

Ratio of interest-earning assets
to interest-bearing liabilities

1.19

1.18

(1)
Loans held-for-sale and non-accruing loans have been included in loans receivable and the effect of such inclusion was not material. Allowance for credit losses has been included in non-interest-earning assets.
(2)
Fair value adjustments have been excluded in the balances of interest-earning assets.
(3)
Includes interest-bearing deposits at other banks and FHLB of New York capital stock.
(4)
Includes average balances of non-interest-bearing deposits o f $624.2 million and $525.0 million for the quarter ended March 31, 2022, and 2021, respectively.
(5)
Interest rate spread represents the difference between the yield on interest-earning assets and the cost of interest-bearing liabilities.
(6)
Net interest margin represents net interest income as a percentage of average interest-earning assets.

Provision for Credit Losses . The provision for credit los ses decreased $5.0 million to a provision for credit losses reversal of $3.9 million for the quarter ended March 31, 2022, compared to a provision for credit losses of $1.1 million for the quarter ended March 31, 2021. The provision reversal for the quarter ended March 31, 2022 was largely attri butable to continued improvement in our economic forecast. In addition, there was a net reduction in reserves on individually evaluated loans primarily related to improved collateral values. By comparison, the provision for the quarter ended March 31, 2021 was largely attributable to increases in qualitative factors associated with the impact of COVID-19 on economic conditions and an increase in reserves on individually evaluated loans of $4.2 million, partially offset by a release of reserves within the one- to four-family residential segment, reflecting the improved credit risk outlook for that asset class.

Additional information regarding the ACL and the associated provisions recognized during the quarters ended March 31, 2022 and 2021 is presented in Note 6 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at March 31, 2022 and June 30, 2021.

- 44 -


Non-Interest Income . Total non-interest income decreased $1.4 million to $3.2 million for the quarter ended March 31, 2022.

Fees and service charges increased $144,000 to $617,000 for the quarter ended March 31, 2022. The increase primarily reflected increases in various deposit-related and loan-related fees and charges.

Gain on sale of loans decreased $567,000 to $376,000 for the quarter ended March 31, 2022. The decrease in loan sale gains largely reflected a lower average sales price of loans sold and a decrease in the volume of loans sold between comparative periods largely attributable to increases in market interest rates.

Other non-interest income decreased $956,000 to $238,000 for the quarter ended March 31, 2022 . The decrease in other non-interest income primarily reflected $837,000 of non-recurring gains on asset disposals recognized in the prior comparative period for which no such gains were recorded in the current period.

The remaining changes in the other components of non-interest income between comparative periods generally reflected normal operating fluctuations within those line items.

Non-Interest Expense . Total non-interest exp ense increased $807,000 to $30.6 million for the quarter ended March 31, 2022.

Salaries and employee benefits increased $2.2 million to $19.2 million for quarter ended March 31, 2022. This increase was largely due to the impact of staff additions, annual merit increases, increases in benefit plan expense, including employee medical, post-retirement plan and ESOP expense, and an increase in incentive payments tied to loan origination volume. Partially offsetting these increases was a decrease in stock-based compensation expense.

Director compensation decreased $408,000 to $340,000 for the quarter ended March 31, 2022. This decrease primarily reflected a decline in director-related stock-based compensation expense.

Other non-interest expense decreased $734,000 to $3.1 million for the quarter ended March 31, 2022. This decrease was primarily attributable to the reversal of provision for credit losses on off-balance sheet credit exposures and a decrease in loan expenses. The decrease was also attributable to non-recurring asset impairment charges of $375,000 related to branch consolidation activity recognized during the prior comparative quarter.

The remaining changes in the other components of non-interest expense between comparative periods generally reflected normal operating fluctuations within those line items.

Provision for Income Taxes . Provision for income taxes increased $790,000 to $6.5 million for the quarter ended March 31, 2022 from $5.7 million for the quarter ended March 31, 2021.

The increase in income tax expense reflected a higher level of pre-tax net income, as compared to the prior period, resulting in a higher provision for income tax expense.

Effective tax rates for the quarter ended March 31, 2022 and 2021 were 26.9% and 25.9%, respectively.

Comparison of Operating Results for the Nine Months Ended March 31, 2022 and March 31, 2021

Net Income . Net income for the nine months ended March 31, 2022 was $56.2 million, or $0.78 per diluted share, compared to $44.8 million, or $0.53 per diluted share for the nine months ended March 31, 2021. The increase in net income reflected an increase in net interest income, a decrease in the provision for credit losses and a decrease in non-interest expense, partially offset by a decrease in non-interest income and an increase in income tax expense.

Net Interest Income . As noted above, effective July 1, 2021, loan prepayment penalty income was reclassified to interest income on loans. Previously, loan prepayment penalty income was recorded within non-interest income. Interest income and non-interest income for all periods presented reflect this reclassification.

Net interest income increased by $6.8 million to $146.0 million for the nine months ended March 31, 2022 compared to $139.2 million for the nine months ended March 31, 2021. The increase between the comparative periods resulted from a decrease of $19.5 million in interest expense, partially offset by a decrease of $12.7 million in interest income. Included in net interest income, for the nine months ended March 31, 2022 and 2021, respectively, was purchase accounting accretion of $7.4 million and $13.5 million and loan prepayment penalty income of $4.5 million and $2.8 million.

- 45 -


Net interest margin increased 18 basis points to 2.95% for the nine months ended March 31, 2022, from 2.77% for the nine months ended March 31, 2021 and reflected a decrease in the average cost of interest-bearing liabilities that was partially offset by a decrease in the average yield on interest-earning assets.

Details surrounding the composition of, and changes to, net interest income are presented in the table below which reflects the components of the average balance sheet and of net interest income for the periods indicated. We derived the average yields and costs by dividing income or expense by the average balance of assets or liabilities, respectively, for the periods presented with daily balances used to derive average balances. No tax equivalent adjustments have been made to yield or costs. Non-accrual loans were included in the calculation of average balances, however interest receivable on these loans has been fully reserved for and therefore not included in interest income. The yields and costs set forth below include the effect of deferred fees, discounts and premiums that are amortized or accreted to interest income or expense.

For the Nine Months Ended March 31,

2022

2021

Average
Balance

Interest

Average
Yield/
Cost

Average
Balance

Interest

Average
Yield/
Cost

(Dollars in Thousands)

Interest-earning assets:

Loans receivable (1)

$

4,836,189

$

141,651

3.91

%

$

4,882,529

$

153,776

4.20

%

Taxable investment securities (2)

1,627,160

23,831

1.95

1,521,839

22,934

2.01

Tax-exempt securities (2)

57,411

976

2.27

78,442

1,297

2.20

Other interest-earning assets (3)

81,078

1,261

2.07

228,075

2,406

1.41

Total interest-earning assets

6,601,838

167,719

3.39

6,710,885

180,413

3.58

Non-interest-earning assets

609,996

624,644

Total assets

$

7,211,834

$

7,335,529

Interest-bearing liabilities:

Interest-bearing demand

$

2,037,725

$

3,446

0.23

$

1,658,437

$

5,727

0.46

Savings

1,092,738

896

0.11

1,049,655

2,874

0.37

Certificates of deposit

1,714,448

6,951

0.54

1,930,970

17,778

1.23

Total interest-bearing deposits

4,844,911

11,293

0.31

4,639,062

26,379

0.76

Borrowings

690,372

10,422

2.01

1,020,472

14,865

1.94

Total interest-bearing liabilities

5,535,283

21,715

0.52

5,659,534

41,244

0.97

Non-interest-bearing liabilities (4)

671,935

572,249

Total liabilities

6,207,218

6,231,783

Stockholders' equity

1,004,616

1,103,746

Total liabilities and stockholders' equity

$

7,211,834

$

7,335,529

Net interest income

$

146,004

$

139,169

Interest rate spread (5)

2.87

%

2.61

%

Net interest margin (6)

2.95

%

2.77

%

Ratio of interest-earning assets
to interest-bearing liabilities

1.19

1.19

(1)
Loans held-for-sale and non-accruing loans have been included in loans receivable and the effect of such inclusion was not material. Allowance for credit losses has been included in non-interest-earning assets.
(2)
Fair value adjustments have been excluded in the balances of interest-earning assets.
(3)
Includes interest-bearing deposits at other banks and FHLB of New York capital stock.
(4)
Includes average balances of non-interest-bearing deposits of $619.5 million and $502.0 million for the nine months ended March 31, 2022, and 2021, respectively.
(5)
Interest rate spread represents the difference between the yield on interest-earning assets and the cost of interest-bearing liabilities.
(6)
Net interest margin represents net interest income as a percentage of average interest-earning assets.

- 46 -


Provision for Credit Losses . The provision for credit losses decreased $15.6 million to a provision for credit losses reversal of $11.7 million for the nine months ended March 31, 2022, compared to a provision for credit losses of $3.8 million for the nine months ended March 31, 2021. The provision reversal for the nine months ended March 31, 2022 was largely attributable to a continued improvement in our economic forecast, a reduction in the expected life of various segments of the loan portfolio and a net reduction in reserves on loans individually evaluated for impairment. By comparison, the provision for the nine months ended March 31, 2021, was largely attributable to an increase of $5.7 million in reserves on individually evaluated loans and $5.1 million of provision expense on non-PCD loans acquired in connection with the acquisition of MSB, partially offset by a release of reserves within the one- to four-family residential segment, reflecting the improved credit risk outlook for that asset class and provision for credit losses reversal associated with a decline in balances of loans collectively evaluated for impairment.

Additional information regarding the ACL and the associated provisions recognized during the nine months ended March 31, 2022 and 2021 is presented in Note 6 to the unaudited consolidated financial statements as well as the Comparison of Financial Condition at March 31, 2022 and June 30, 2021.

Non-Interest Income . Total non-interest income decreased $6.4 million to $11.1 million for the nine months ended March 31, 2022.

Fees and service charges increased $448,000 to $1.9 million for the nine months ended March 31, 2022. The increase primarily reflected increases in loan-related and deposit-related fees and charges.

Gain on sale and call of securities reflected a net gain of $4,000 during the nine months ended March 31, 2022 compared to a net gain of $454,000 recorded during the earlier comparative period.

Gain on sale of loans decreased $2.9 million to $2.4 million for the nine months ended March 31, 2022. The decrease in loan sale gains largely reflected a decrease in the volume of loans sold between comparative periods and a lower average sales price of loans sold.

Bargain purchase gain recognized in the prior comparative period in connection with our acquisition of MSB was $3.1 million. No such gain was recorded in the current period.

Other non-interest income decreased $413,000 to $938,000 for the nine months ended March 31, 2022. The decrease primarily reflected a $356,000 non-recurring gain on asset disposals recognized in the current period compared to $837,000 of non-recurring gains on asset disposals recorded in the prior period.

The remaining changes in the other components of non-interest income between comparative periods generally reflected normal operating fluctuations within those line items.

Non-Interest Expense . Total non-interest expense decreased $1.8 million to $92.1 million for the nine months ended March 31, 2022.

Salaries and employee benefits increased $4.9 million to $55.9 million for the nine months ended March 31, 2022. This increase was largely due to the impact of staff additions, annual merit increases, increases in benefit plan expense, including employee medical, post-retirement plan and ESOP expense, and an increase in incentive payments tied to loan origination volume. Partially offsetting these increases was a decrease in stock-based compensation expense.

Net occupancy expense of premises increased $1.3 million to $10.9 million for the nine months ended March 31, 2022. This increase was primarily due to non-recurring expenses of $1.3 million related to the consolidation of three retail branch locations, $250,000 related to facility repairs made in connection with damage incurred during Tropical Storm Ida and $187,000 related to the closure of a leased office facility acquired in conjunction with the MSB acquisition.

Director compensation decreased $452,000 to $1.8 million for the nine months ended March 31, 2022. This decrease primarily reflected a decline in director-related stock-based compensation expense.

Merger-related expenses, associated with our acquisition of MSB, totaled $4.3 million for the nine months ended March 31, 2021 for which no such costs were recorded in the current period.

Debt extinguishment expenses totaled $796,000 for the nine months ended March 31, 2021 for which no such costs were recorded in the current period.

Other non-interest expense decreased $2.4 million to $9.1 million for the nine months ended March 31, 2022. This decrease was primarily attributable to the reversal of provision for credit losses on off-balance sheet credit exposures and a decrease in loan expenses. The decrease was also attributable to non-recurring asset impairment charges related to branch consolidation activity of $420,000 in the current period compared to $722,000 during the prior period.

- 47 -


The remaining changes in the other components of non-interest expense between comparative periods generally reflected normal operating fluctuations within those line items.

Provision for Income Taxes . Provision for income taxes increased $6.4 million to $20.6 million for the nine months ended March 31, 2022, from $14.2 million for the nine months ended March 31, 2021.

The increase in income tax expense reflected a higher level of pre-tax net income, as compared to the prior period, resulting in a higher provision for income tax expense. The increase also reflected the effects of various non-recurring items recorded in conjunction with our acquisition of MSB, recorded in the prior comparative period, including non-deductible merger related expenses, which were partially offset by a non-taxable bargain purchase gain. The change in income tax expense also reflected the reversal of a valuation allowance totaling $535,000 which was associated with the realization of a capital loss carryforward recorded in the prior comparative period for which no such amount was recorded in the current period.

Effective tax rates for the nine months ended March 31, 2022 and 2021 were 26.8% and 24.1%, respectively. The effective tax rate for the prior comparative period reflected the effects of various non-recurring items recorded in conjunction with our acquisition of MSB and reversal of a valuation allowance, as noted above.

Liquidity and Capital Resources

Liquidity, represented by cash and cash equivalents, is a product of operating, investing and financing activities. Our primary sources of funds are deposits, borrowings, cash flows from investment securities and loans receivable and funds provided from operations. While scheduled payments from the amortization and maturity of loans and investment securities are relatively predictable sources of funds, general interest rates, economic conditions and competition greatly influence deposit flows and prepayments on loans and securities.

At March 31, 2022, liquidity included $62.4 million of short-term cash and equivalents supplemented by $1.53 billion of investment securities classified as available for sale. In addition, as of March 31, 2022, we had the capacity to borrow additional funds totaling $2.38 billion and $312.5 million from the FHLB of New York and FRB, respectively, without pledging additional collateral. As of that same date, we also had access to unsecured overnight borrowings with other financial institutions totaling $950.0 million of which $310.0 million was outstanding.

At March 31, 2022, we had outstanding commitments to originate and purchase loans totaling approximately $198.1 million while such commitments totaled $192.8 million at June 30, 2021. As of those same dates, our pipeline of loans held for sale included $16.0 million and $48.4 million, respectively, of loans in process whose terms included interest rate locks to borrowers that were paired with a non-binding, best-efforts commitment to sell the loan to a buyer at a fixed price and within a predetermined timeframe after the sale commitment is established.

Construction loans in process and unused lines of credit were $88.2 million and $165.8 million, respectively, at March 31, 2022 compared to $138.3 million and $181.1 million, respectively, at June 30, 2021. We are also subject to the contingent liabilities resulting from letters of credit whose outstanding balances totaled $180,000 and $739,000, at March 31, 2022 and June 30, 2021, respectively.

Commitments to extend credit are agreements to lend to a customer as long as there is no violation of any condition established in the contract. Commitments generally have fixed expiration dates or other termination clauses and may require payment of a fee by the customer. Our exposure to credit loss in the event of nonperformance by the other party to the financial instrument for commitments to extend credit is represented by the contractual notional amount of those instruments. We use the same credit policies in making commitments and conditional obligations as we do for on-balance-sheet instruments. Since many of the commitments are expected to expire without being drawn upon, the total commitment amounts do not necessarily represent future cash requirements.

Consistent with its goals to operate a sound and profitable financial organization, the Bank actively seeks to maintain its status as a well-capitalized institution in accordance with regulatory standards.

- 48 -


The following table sets forth the Bank’s capital position at March 31, 2022 and June 30, 2021, as compared to the minimum regulatory capital requirements that were in effect as of those dates:

At March 31, 2022

Actual

For Capital
Adequacy Purposes

To Be Well Capitalized
Under Prompt
Corrective Action
Provisions

Amount

Ratio

Amount

Ratio

Amount

Ratio

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

668,961

14.14

%

$

378,457

8.00

%

$

473,071

10.00

%

Tier 1 capital (to risk-weighted assets)

641,798

13.57

%

283,843

6.00

%

378,457

8.00

%

Common equity tier 1 capital (to risk-weighted assets)

641,798

13.57

%

212,882

4.50

%

307,496

6.50

%

Tier 1 capital (to adjusted total assets)

641,798

9.14

%

280,960

4.00

%

351,200

5.00

%

At June 30, 2021

Actual

For Capital
Adequacy Purposes

To Be Well Capitalized
Under Prompt
Corrective Action
Provisions

Amount

Ratio

Amount

Ratio

Amount

Ratio

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

761,883

17.22

%

$

353,970

8.00

%

$

442,462

10.00

%

Tier 1 capital (to risk-weighted assets)

726,737

16.42

%

265,477

6.00

%

353,970

8.00

%

Common equity tier 1 capital (to risk-weighted assets)

726,737

16.42

%

199,108

4.50

%

287,600

6.50

%

Tier 1 capital (to adjusted total assets)

726,737

10.23

%

284,114

4.00

%

355,142

5.00

%

The following table sets forth the Company’s capital position at March 31, 2022 and June 30, 2021, as compared to the minimum regulatory capital requirements that were in effect as of those dates:

At March 31, 2022

Actual

For Capital
Adequacy Purposes

Amount

Ratio

Amount

Ratio

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

802,929

16.97

%

$

378,574

8.00

%

Tier 1 capital (to risk-weighted assets)

775,766

16.39

%

283,931

6.00

%

Common equity tier 1 capital (to risk-weighted assets)

775,766

16.39

%

212,948

4.50

%

Tier 1 capital (to adjusted total assets)

775,766

11.04

%

281,055

4.00

%

At June 30, 2021

Actual

For Capital
Adequacy Purposes

Amount

Ratio

Amount

Ratio

(Dollars in Thousands)

Total capital (to risk-weighted assets)

$

872,823

19.65

%

$

355,274

8.00

%

Tier 1 capital (to risk-weighted assets)

837,677

18.86

%

266,456

6.00

%

Common equity tier 1 capital (to risk-weighted assets)

837,677

18.86

%

199,842

4.50

%

Tier 1 capital (to adjusted total assets)

837,677

11.76

%

284,877

4.00

%

In March 2020, the federal banking agencies announced an interim final rule to delay the estimated impact on regulatory capital stemming from the implementation of CECL. The interim final rule provides banks the option to delay for two years an estimate of CECL’s effect on regulatory capital, relative to the incurred loss method, followed by a three-year transition period established in the previous rule (five-year transition option). We have adopted the capital transition relief over the permissible five-year period.

- 49 -


Off-Balance Sheet Arrangements

In the normal course of our business of investing in loans and securities we are a party to financial instruments with off-balance-sheet risk. These financial instruments include significant purchase commitments, such as commitments related to capital expenditure plans and commitments to extend credit to meet the financing needs of our customers. We had no significant off-balance sheet commitments for capital expenditures as of March 31, 2022.

Recent Accounting Pronouncements

For a discussion of the expected impact of recently issued accounting pronouncements that we have yet to adopt, please refer to Note 3 to the unaudited consolidated financial statements.

- 50 -


ITEM 3.

Q UANTITATIVE AND QUALITATIVE DISCLOSURE ABOUT MARKET RISK

The majority of our assets and liabilities are sensitive to changes in interest rates and as such interest rate risk is a significant form of market risk that we must manage. Interest rate risk is generally defined in regulatory nomenclature as the risk to earnings or capital arising from the movement of interest rates and arises from several risk factors including re-pricing risk, basis risk, yield curve risk and option risk. We maintain an Asset/Liability Management (“ALM”) program in order manage our interest rate risk. The program is overseen by the Board of Directors through its Interest Rate Risk Management Committee which has assigned the responsibility for the operational aspects of the ALM program to our Asset/Liability Management Committee (“ALCO”), which is comprised of various members of the senior and executive management team.

The quantitative analysis that we conduct measures interest rate risk from both a capital and earnings perspective. With regard to earnings, movements in interest rates and the shape of the yield curve significantly influence the amount of net interest income (“NII”) that we recognize. Movements in market interest rates, and the effect of such movements on the risk factors noted above, significantly influence the spread between the interest earned on our interest-earning assets and the interest paid on our interest-bearing liabilities. Our internal interest rate risk analysis calculates the sensitivity of our projected NII over a one year period utilizing a static balance sheet assumption through which incoming and outgoing asset and liability cash flows are reinvested into similar instruments. Product pricing and earning asset prepayment speeds are appropriately adjusted for each rate scenario.

With regard to capital, our internal interest rate risk analysis calculates the sensitivity of our Economic Value of Equity (“EVE”) to movements in interest rates. EVE represents the present value of the expected cash flows from our assets less the present value of the expected cash flows arising from our liabilities adjusted for the value of off-balance sheet instruments. EVE attempts to quantify our economic value using a discounted cash flow methodology. The degree to which our EVE changes for any hypothetical interest rate scenario from its base case measurement is a reflection of our sensitivity to interest rate risk.

For both earnings and capital at risk, our interest rate risk analysis calculates a base case scenario that assumes no change in interest rates. The model then measures changes throughout a series of interest rate scenarios representing immediate and permanent, parallel shifts in the yield curve up and down 100, 200 and 300 basis points with additional scenarios modeled where appropriate. The model requires that interest rates remain positive for all points along the yield curve for each rate scenario which may preclude the modeling of certain falling rate scenarios during periods of lower market interest rates. The relatively low level of interest rates prevalent at March 31, 2022 and June 30, 2021 precluded the modeling of certain falling rate scenarios.

The following tables present the results of our internal EVE and NII analyses as of March 31, 2022 and June 30, 2021, respectively:

March 31, 2022

1 to 12 Months

13 to 24 Months

Change in
Interest Rates

$ Amount
of EVE

% Change
in EVE

$ Amount
of NII

% Change
in NII

$ Amount
of NII

% Change
in NII

(Dollars in Thousands)

+300 bps

1,139,213

(11.91

)

%

182,874

(10.70

)

%

216,395

3.42

%

+200 bps

1,191,919

(7.84

)

%

189,586

(7.43

)

%

213,631

2.10

%

+100 bps

1,261,373

(2.47

)

%

199,005

(2.83

)

%

213,632

2.10

%

0 bps

1,293,258

-

204,792

-

209,236

-

-100 bps

1,244,971

(3.73

)

%

196,007

(4.29

)

%

190,088

(9.15

)

%

June 30, 2021

1 to 12 Months

13 to 24 Months

Change in
Interest Rates

$ Amount
of EVE

% Change
in EVE

$ Amount
of NII

% Change
in NII

$ Amount
of NII

% Change
in NII

(Dollars in Thousands)

+300 bps

1,083,847

(8.82

)

%

175,830

(8.38

)

%

196,307

4.11

%

+200 bps

1,132,915

(4.69

)

%

182,089

(5.12

)

%

195,756

3.82

%

+100 bps

1,176,890

(0.99

)

%

187,961

(2.06

)

%

194,543

3.17

%

0 bps

1,188,656

-

191,908

-

188,559

-

-100 bps

1,071,463

(9.86

)

%

181,645

(5.35

)

%

169,447

(10.14

)

%

At March 31, 2022, our interest rate risk analysis was impacted by $310.0 million of overnight borrowings, compared to $20.0 million of overnight borrowings at June 30, 2021. This increased level of overnight borrowings resulted in a relatively greater level of interest rate sensitivity in the rising rate shock scenarios and does not reflect any future actions we may take to replace or extend the maturity of these borrowings.

- 51 -


There are numerous internal and external factors that may contribute to changes in our EVE and its sensitivity. Changes in the composition and allocation of our balance sheet, or utilization of off-balance sheet instruments such as derivatives, can significantly alter the exposure to interest rate risk as quantified by the changes in the EVE sensitivity measures. Changes to certain external factors, most notably changes in the level of market interest rates and overall shape of the yield curve, can also alter the projected cash flows of our interest-earning assets and interest-costing liabilities and the associated present values thereof.

Notwithstanding the rate change scenarios presented in the EVE and NII-based analyses above, future interest rates and their effect on net interest income are not predictable. Computations of prospective effects of hypothetical interest rate changes are based on numerous assumptions, including relative levels of market interest rates, prepayments and deposit run-offs and should not be relied upon as indicative of actual results. Certain shortcomings are inherent in this type of computation. Although certain assets and liabilities may have similar maturities or periods of re-pricing, they may react at different times and in different degrees to changes in market interest rates. The interest rate on certain types of assets and liabilities, such as demand deposits and savings accounts, may fluctuate in advance of changes in market interest rates, while rates on other types of assets and liabilities may lag behind changes in market interest rates. Certain assets, such as adjustable-rate mortgages, generally have features which restrict changes in interest rates on a short-term basis and over the life of the asset. In the event of a change in interest rates, prepayments and early withdrawal levels could deviate significantly from those assumed in the analyses set forth above. Additionally, an increase in credit risk may result as the ability of borrowers to service their debt may decrease in the event of an interest rate increase.

ITEM 4.

C ONTROLS AND PROCEDURES

As of the end of the period covered by this Report, an evaluation was performed under the supervision and with the participation of the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, of the effectiveness of the design and operation of the Company’s disclosure controls and procedures (as defined in Rule 13a-15(e) and 15d-15(e) promulgated under the Securities Exchange Act of 1934, as amended). Based on that evaluation, the Company’s management, including the Chief Executive Officer and the Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective.

During the quarter ended March 31, 2022, there were no changes in the Company’s internal control over financial reporting (as defined in Rule 13a-15(f) under the Securities Exchange Act of 1934) that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.

- 52 -


PART II

At March 31, 2022, neither the Company nor the Bank were involved in any pending legal proceedings other than routine legal proceedings occurring in the ordinary course of business, which involve amounts in the aggregate believed by management to be immaterial to the financial condition of the Company and the Bank.

ITEM 1A. Risk Factors

There have been no material changes to the Risk Factors previously disclosed under Item 1A of the Company’s Annual Report on Form 10-K for the year ended June 30, 2021, previously filed with the Securities and Exchange Commission.

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds

Issuer Purchases of Equity Securities:

The following table reports information regarding repurchases of the Company’s common stock during the quarter ended March 31, 2022:

Period

Total Number
of Shares
Purchased

Average Price
Paid per Share

Total Number
of Shares
Purchased as
Part of Publicly
Announced Plans
or Programs

Maximum
Number of Shares
that May Yet Be
Purchased Under
the Plans or
Programs

January 1-31, 2022

599,585

$

13.49

599,585

4,499,760

February 1-28, 2022

751,431

$

13.37

751,431

3,748,329

March 1-31, 2022

668,609

$

13.21

668,609

3,079,720

Total

2,019,625

$

13.35

2,019,625

3,079,720

On September 22, 2021, the Company announced the authorization of a new stock repurchase plan to repurchase up to 7,602,021 shares, or 10% of the shares then outstanding. This current plan has no expiration date.

ITEM 3. Defaults Upon Senior Securities

Not applicable.

ITEM 4. Mine Safety Disclosures

Not applicable.

ITEM 5. Other Information

None.

- 53 -


ITE M 6. Exhibits

The following Exhibits are filed as part of this report:

3.1

Articles of Incorporation of Kearny Financial Corp. (Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 333-198602), originally filed on September 5, 2014)

3.2

Bylaws of Kearny Financial Corp. (Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 333-198602), originally filed on September 5, 2014)

4

Form of Common Stock Certificate of Kearny Financial Corp. (Incorporated by reference to the Registrant’s Registration Statement on Form S-1 (File No. 333-198602), originally filed on September 5, 2014)

10.1

Kearny Bank Amended and Restated Change in Control Severance Pay Plan

31.1

Certification of Chief Executive Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

31.2

Certification of Chief Financial Officer pursuant to Section 302 of the Sarbanes-Oxley Act of 2002

32.1

Certification of Chief Executive Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

32.2

Certification of Chief Financial Officer pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

101

The following materials from the Company’s Form 10-Q for the quarter ended March 31, 2022, formatted in Inline XBRL (Extensible Business Reporting Language): (i) the Consolidated Statements of Financial Condition, (ii) the Consolidated Statements of Income; (iii) the Consolidated Statements of Comprehensive Income, (iv) the Consolidated Statements of Changes in Stockholder’s Equity, (v) the Consolidated Statements of Cash Flows and (vi) the Notes to Consolidated Financial Statements.

101.INS

Inline XBRL Instance Document (The instance document does not appear in the interactive data file because its XBRL tags are embedded within the Inline XBRL document)

101.SCH

Inline XBRL Taxonomy Extension Schema Document

101.CAL

Inline XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF

Inline XBRL Taxonomy Extension Definition Linkbase Document

101.LAB

Inline XBRL Taxonomy Extension Labels Linkbase Document

101.PRE

Inline XBRL Taxonomy Extension Presentation Linkbase Document

104

Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)

- 54 -


SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

KEARNY FINANCIAL CORP.

Date: May 6, 2022

By:

/s/ Craig L. Montanaro

Craig L. Montanaro

President and Chief Executive Officer

(Principal Executive Officer)

Date: May 6, 2022

By:

/s/ Keith Suchodolski

Keith Suchodolski

Executive Vice President and Chief Financial Officer

(Principal Financial and Accounting Officer)

- 55 -


TABLE OF CONTENTS